Expression of steroidogenic proteins and genes in bovine placenta from conventional and somatic cell nuclear transfer (SCNT) gestations by Verduzco Gomez, Adriana Rebeca
  
Université de Montréal 
 
 
EXPRESSION OF STEROIDOGENIC PROTEINS AND GENES IN BOVINE PLACENTA FROM CONVENTIONAL 
AND SOMATIC CELL NUCLEAR TRANSFER (SCNT) GESTATIONS 
 
 
par 
ADRIANA REBECA VERDUZCO GÓMEZ 
 
 
Département de biomédecine vétérinaire  
Faculté de médecine vétérinaire 
 
 
Thèse présentée à la Faculté de médecine vétérinaire 
en vue de l’obtention du grade de 
philosophiae doctor (Ph.D.) 
en sciences vétérinaires 
option reproduction 
 
 
Décembre, 2010 
 
 
©Adriana Rebeca Verduzco Gómez, 2010
  
 
Université de Montréal 
Faculté de médecine vétérinaire 
 
 
 
 
Cette thèse intitulée 
 
EXPRESSION OF STEROIDOGENIC PROTEINS AND GENES IN BOVINE PLACENTA FROM 
CONVENTIONAL AND SOMATIC CELL NUCLEAR TRANSFER (SCNT) GESTATIONS 
 
 
 
présentée par 
 
ADRIANA REBECA VERDUZCO GÓMEZ 
 
 
a été évaluée par un jury composé des personnes suivantes 
 
 
Paul D. Carrière,  président-rapporteur 
 
 
Bruce D. Murphy,  directeur de recherche 
 
 
Lawrence C. Smith, membre du jury 
 
 
Éric Asselin, examinateur externe 
 
 
 Alan K. Goff, représentant du doyen 
 
iii 
 
RÉSUMÉ 
Pendant la grossesse, les hormones stéroïdes jouent un rôle indispensable dans la 
régulation des principales manifestations physiologiques telles que la reconnaissance 
maternelle de la gestation, la réceptivité de l'endomètre, le début du développement 
embryonnaire ainsi que le maintien de la gestation. Cependant, on sait très peu sur la 
production de ces hormones et les principaux facteurs des voies intracellulaires impliqués 
dans le processus de stéroïdogenèse dans le placenta bovin pendant les stades initiaux et 
plus avancés de la gestation. Par ailleurs, certaines anomalies du placenta chez les bovins 
suite à une mauvaise production de stéroïdes n'ont pas encore été démontrées. Les 
objectifs de cette thèse étaient donc de : 1) déterminer la présence et la localisation des 
principales protéines stéroïdiennes dans le placenta de bovins provenant de gestations de 
50 à 120 jours, 2) comparer l'expression placentaire d'une série de gènes et de protéines 
stéroïdiennes entre une gestation impliquant un transfert de noyaux de cellules 
somatiques (SCNT) et une gestation non-clonale; 3) étudier l'impact des hormones 
trophiques et des seconds messagers  sur la stéroïdogenèse dans le placenta bovin à 140 
+10 jours de gestation. 
L’utilisation de techniques d’immunohistochimie, d’immunobuvardage et de PCR 
quantitatif nous a permis d’évaluer la présence d'un large éventail de gènes stéroïdiens 
(STAR, CYP11A1, HSD3B1, CYP17A1 et SCARB1) qui participent au transport du cholestérol 
et dans la production de différents types de stéroïdes. Dans cette thèse, nous avons 
démontré la capacité du placenta bovin d’initier la stéroïdogenèse au début de la gestation  
et nous avons également déterminé les principales cellules impliquées dans ce processus. 
Nous avons constaté que les tissus maternels expriment les principaux marqueurs de 
stéroïdogenèse suggérant une plus grande capacité stéroïdogénique que les tissus fœtaux. 
En outre, un modèle d'expression des protéines complémentaires stéroïdogéniques entre 
la caroncule et le cotylédon a été observé, indiquant que la stéroïdogenèse placentaire 
exige une communication cellule à cellule entre les cellules de la mère et du fœtus. 
Après avoir démontré les principales cellules impliquées dans la synthèse des 
hormones stéroïdiennes dans le placenta bovin en début de gestation, nous avons ensuite 
étudié les modifications possibles de la stéroïdogenèse dans les tissus SCNT cotylédonaires 
à 40 jours de gestation. Nous avons identifié d'importantes modifications dans l'expression 
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des gènes STAR, CYP11A1, HSD3B1, CYP17A1, et SULT1E1. Conséquemment, nous postulons 
que l'expression réduite des gènes stéroïdiens peut provoquer une insuffisance de la 
biosynthèse des hormones stéroïdiennes, ce qui pourrait contribuer à un développement 
anormal du placenta et du fœtus dans les gestations SCNT à court ou long terme. 
Finalement, nous avons développé un modèle efficace de culture d’explants de 
placentome qui nous a permis d'explorer les mécanismes sous-jacents spécifiques à la 
stéroïdogenèse placentaire. Nous avons exploré l'effet stimulant des hormones trophiques 
et différents messagers secondaires sur l'expression de différentes protéines 
stéroïdogéniques ainsi que le taux de progestérone (P4) dans les explants de placentome. 
En utilisant les techniques de RIA et de PCR quantitatif, nous avons constaté que même si 
les analogues de l'hormone lutéinisante (hCG) ont un effet stimulant sur plusieurs gènes 
stéroïdiens, le calcium ionophore est le principal modulateur dans la synthèse de la P4. Ces 
résultats suggèrent que dans le placenta bovin, la synthèse de la P4 est modulée 
principalement par l'afflux de calcium intracellulaire, et apparemment les nucléotides 
cycliques ne semblent pas contrôler ce processus. 
En conclusion, cette étude contribue de manière significative à une meilleure 
compréhension des mécanismes d'entraînement de la synthèse des stéroïdes placentaires 
au début de la gestation et permet aussi d’apporter de nouveaux éclairages sur 
l'importance des stéroïdes placentaires dans la régulation du développement du placenta 
et du fœtus. 
Mots-clefs : placenta bovin, stéroïdes placentaires, stéroïdogenèse, gestation SCNT. 
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ABSTRACT 
During pregnancy, steroid hormones have essential roles in regulating key 
physiological events such as maternal recognition, endometrial receptivity, early 
embryonic development, and maintenance of pregnancy. However, very little is 
known about the production of these hormones nor about the principal factors and 
intracellular pathways implicated in the steroidogenic process in bovine placenta, 
during early and advanced pregnancy. In addition, placental abnormalities in cattle 
following an improper steroid production in bovine placenta have not been yet 
demonstrated. The aims of this thesis were to: 1) determine the occurrence and 
localization of the principal steroidogenic proteins in bovine placenta from day 50 
to day 120 of pregnancy; 2) compare the placental expression of a series of 
steroidogenic genes and proteins between somatic cell nuclear transfer (SCNT) 
pregnancies and non-SCNT gestations; 3) investigate the impact of trophic 
hormone, and second messengers on steroidogenesis in bovine placenta at 140 +10 
days of gestation.  
Using immunohistochemistry, western blot and qPCR techniques, we 
evaluated the presence of a wide range of steroidogenic genes (STAR, CYP11A1, 
HSD3B1, CYP17A1 and SCARB1), that participate in the cholesterol transport and in 
the production of different types of steroids. In this thesis, we demonstrated the 
capability of the early bovine placenta to initiate steroidogenesis, and we also 
determined the principal cells implicated in this process. We found that maternal 
tissue expresses the principal steroidogenic markers suggesting it has a greater 
steroidogenic capacity compared to fetal tissue. Moreover, a complementary 
pattern of steroidogenic protein expression between the caruncle and the 
cotyledon were found, indicating that placental steroidogenesis requires cell to cell 
communication between the maternal and fetal cells. 
Having shown the principal cells involved in the synthesis of steroid 
hormones in bovine placenta during early pregnancies, we then studied possible 
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alterations in steroidogenesis in cotyledonary tissue in SCNT at 40 days of 
pregnancy. We identified significant alterations in the expression of STAR, 
CYP11A1, HSD3B1, CYP17A1 and SULT1E1 transcripts. Therefore, we postulate that 
reduced expression of steroidogenic genes may cause an insufficient local 
biosynthesis of steroid hormones, which might contribute to the abnormal 
placental and fetal development in SCNT gestations at short or long term. 
Finally, we developed an efficient placentome explants culture model that 
allowed us to explore the specific mechanisms underlying placental 
steroidogenesis. We explored the stimulatory effect of trophic hormones and 
different second messengers on the expression of various steroidogenic proteins 
and the progesterone levels in placentome explants.  By RIA and qPCR techniques, 
we found that although LH-like hormones (hCG), had a stimulatory effect on 
multiple steroidogenic genes, the calcium ionophore was the principal modulator 
in the synthesis of progesterone. These results suggest that in bovine placenta, the 
synthesis of progesterone is modulated principally by intracellular calcium influx, 
and cyclic nucleotides do not seem to be controlling this process.  
In conclusion, these studies significantly contribute to a better 
understanding of the driving mechanisms of placental steroid synthesis in early 
gestations and also provide new insights into the importance of placental steroids 
in the regulation of placental and fetal development.  
Key words: Bovine placenta, placental steroids, steroidogenesis, SCNT gestation. 
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In the last decade, the manipulation of gametes and embryos in farm animals has 
improved significantly. New reproductive biotechnologies have had a great impact 
in the development of the productive and reproductive fields, and are powerful 
tools that may provide a solution to the coming world food demands.  SCNT 
technology has many potential applications in basic research, medicine and 
agriculture. Some examples of the potential benefits and research applications of 
this technology, including conservation of animal genetic resources, study of 
genetic and epigenetic mechanisms underlying developmental biology, aging and 
carcinogenesis and preservation of endangered species (Tong, et al., 2002; 
Mastromonaco & King, 2007; Murphey, et al., 2009; Rodriguez-Osorio, et al., 2009; 
Liu, et al., 2010). Although bovine cloning by SCNT has improved significantly in the 
last decade, the cloning process remains largely inefficient because of losses during 
gestation. In cattle, most SCNT pregnancies are lost in the first trimester and 
resulting  from abnormalities of the embryo or its placenta or alterations in 
maternal uterine environment or fetomaternal interactions (Wilmut, et al., 1986; 
Wilmut, et al., 1997; Cibelli, et al., 1998; Wells, et al., 1999; Koo, et al., 2002; Pace, et 
al., 2002).  A variety of placental dysfunctions have been reported for the SCNT 
pregnancies, including fewer placentomes, rudimentary and reduced number of 
cotyledons, increased caruncular weight, failures in development of the allantois, 
and abnormalities of placental vasculature (Hill, et al., 2000; Hashizume, et al., 
2002; Lee, et al., 2004; Farin, et al., 2006). Faulty gene expression during 
implantation and placentogenesis has been suggested to contribute to the 
pathologies observed in cloned offspring.  
3 
 
Variations in the pattern of expression found in some genes, proteins and factors 
which control placental growth (IGF1, IGF2, IGF2R, IGFBP1, IGFBP2, VEGFA, 
VEGFR-2, DKK1 and PHLDA2), have been associated with placental dysfunction, 
restraining placental growth, delayed parturition and a generalized hypoxic 
condition in early placental tissues in SCNT pregnancies (Ravelich, et al., 2004) 
(Ledgard, et al., 2009; Perecin, et al., 2009; Campos, et al., 2010).  
Among the key functions of the placenta is the production of steroid 
hormones, such as progesterone, estrogens and sulfoconjugated estrogens. 
Placental steroid hormones are required for pregnancy recognition, maternal 
support of conceptus, regulation of proliferation and/or differentiation of glandular 
epithelium, conceptus-uterine interactions, placental vascular development and 
process of parturition (Pepe & Albrecht, 1995; Spencer, et al., 2004; Mesiano & 
Welsh, 2007; Johnson, et al., 2010).  In addition, excess of estrogen sulfoconjugation 
is the possible cause for a poor sign of parturition in SCNT pregnancies (Hirayama, 
et al., 2008). Nonetheless, in SCNT gestations, little is known about sub-optimal 
steroid synthesis, and its possible impact in the placental and fetal development.   
Previous research in bovine gestation has demonstrated that ruminant 
placenta produces estrogens and progesterone, and, as mentioned before, these 
hormones are important factors controlling caruncular growth, differentiation and 
function, and also inducing histotrophic and hematotrophic support (Hoffmann & 
Schuler, 2002; Dunlap, et al., 2008; Schuler, et al., 2008). Furthermore, estrogen and 
progesterone receptors are present in bovine placenta, suggesting that placental 
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steroids act as local regulators of placental growth (Hoffmann & Schuler, 2002). 
Nevertheless, further research is needed to identify the underlying processes of 
steroidogenesis in bovine placenta on a molecular level. 
Given the importance of steroid hormones in placental and fetal 
development, the objectives of this PhD project were to understand the 
mechanisms involved in the regulation of steroid synthesis by bovine placenta, and 
to explore if abnormalities in bovine cloned pregnancies may originate from 
disturbed placental steroidogenesis. 
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2.1. PREGNANCY  
2.1.1. Definition and general aspects of pregnancy  
Pregnancy is defined as a condition where there is carrying of an embryo or 
fetus inside a female viviparous animal. Establishment and maintenance of 
pregnancy is an intricate and complex interaction between the conceptus and the 
mother that comprises pregnancy recognition, endometrial receptivity, 
implantation, placental and fetal development and parturition. In most species, a 
complex dialogue between the embryo and the uterus is initiated immediately after 
fertilization with remarkable and visible micro-remodeling of the endometrium, 
followed somewhat later by  embryo implantation (Hashizume, 2007; Lefevre, et 
al., 2007).  
2.1.2. Pregnancy recognition  
In ruminants, pregnancy recognition is the physiological process whereby 
the conceptus signals its presence to the maternal system and prolongs lifespan of 
the corpus luteum (CL), allowing it to continue to secrete progesterone (Spencer, et 
al., 2004).  Progesterone is the hormone of pregnancy and unequivocally required 
in all mammals to stimulate and maintain the uterine functions that will facilitate 
the early embryonic development, implantation, placentation, and successful fetal 
and placental development to term (Spencer & Bazer, 2002; Spencer & Bazer, 
2004). The role of progesterone and other steroid hormones during gestation will 
be discussed in more detail in later sections of this review. As mentioned before, 
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recognition of ruminant pregnancy requires conceptus signals, which alter 
endometrial physiology, resulting in establishment of the pregnancy. Precisely 
timed embryo recognition in the genital tract is essential for establishment of an 
optimal maternal environment for embryo implantation (Spencer, et al., 2007). A 
deficient signal leads to luteolysis, progesterone level decline and finally, 
pregnancy loss. The pregnancy recognition factors, critical days of pregnancy 
recognition and time of conceptus attachment in different mammal species are 
shown in the following table: 
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Table 1. Pregnancy recognition factors. 
 
Species Pregnancy Recognition Factors 
Critical Period for 
Recognition (days 
after ovulation) 
 
Bitch 
 
None needed ____ 
Cow Elongation of the blastocyst and synthesis of interferon-tau 
(INFT). INFT prevents development of the endometrial 
luteolytic mechanism 
15-16
Ewe 13-14
Mare Embryo produces substantial amounts of estrogens and 
prostaglandins. The aforementioned factors apparently 
facilitate the continuously migration of equine conceptus 
throughout the uterine lumen, avoiding the luteolysis. 
9-16
Sow Estradiol (E2) produced by conceptuses induces a transient 
release of calcium into the lumen, changing the direction of 
endometrial secretion of prostaglandins from an endocrine 
to an exocrine orientation. 
10-12
Mouse Prolactin release caused by stimulation of the pelvic nerve 
and activation of a neural reflex arc. 
Zona pellucida (ZP) derivatives can act as an intrinsic signal 
from the developing embryo for maternal recognition by 
the immune system. 
Before 4 days 
Woman Embryo produces human chorionic gonadotrophin (hCG), 
which interacts with luteinizing hormone LH/hCG receptor 
and promotes the maintenance of the CL. 
7-12
  
(Bazer & Roberts, 1983; Gandolfi, et al., 1992; Roberts, et al., 1996; Duc-Goiran, et 
al., 1999; Spencer, et al., 2004; Spencer, et al., 2004; Senger, 2005; Bazer, et al., 
2008; Fujiwara, et al., 2009; Walker, et al., 2009; Farin, et al., 2010; Klein, et al., 
2010).  
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2.1.3. Animal models of implantation  
The embryo implantation is a complex process where local paracrine signaling 
between embryo and the endometrium occurs in order to obtain a strong 
attachment between them. In species with invasive placenta, the free floating 
blastocyst attaches to the maternal endometrium, invades into the stroma and 
establishes the placenta. This requires a synchronization of a viable blastocyst to 
implant and an endometrium able to respond to embryonic signals. There is 
diversity in types and time of implantation among species (see _Table. 2). 
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Table 2. Different types of placenta, implantation and time of attachment.  
Species Time of attachment 
(time after 
ovulation) 
Implantation 
type 
Placenta type 
 
Cow 
 
18-22 days 
 
Caruncular areas 
Centric 
 
Syndesmochorial 
Cotyledonary 
Ewe 15-18 days Caruncular areas 
Centric 
Syndesmochorial 
Epitheliochorial 
Cotyledonary 
Sow 14-18 days Superficial and 
centric 
Epitheliochorial 
Diffuse 
Mare 36-38 days Endometrial 
surface 
Epitheliochorial 
Diffuse 
Mice and rats Day 4 (mouse) 
Day 5 (rat) 
Eccentric Discoid 
Memoendothelial 
Woman 9 days Interstitial Discoid 
Hemochorial 
(Dey, et al.; Lee & DeMayo, 2004; Senger, 2005) 
 
 
11 
 
In general, the first step in implantation after the preattachement is when 
cells of the trophectoderm from the blastocyst migrate between the epithelial cells, 
displacing them and penetrating as far as the basement membrane. The second 
step is when the trophoblast cells invade through the basal membrane coming in 
contact with the maternal stroma. The final step in this process is the 
decidualization, which consists of transformation of the endometrial stromal cells 
in highly secretory cells to prepare the endometrium for implantation (Sharkey & 
Smith, 2003) (see figure. 1). 
 
 
 
Figure 1. Cartoon representing the initial phases of murine implantation. During 
the pre-attachment phase, the embryo uses endocrine and paracrine mediators to 
signal its presence to the mother. Following apposition and attachment, the embryo 
invades and promotes decidualization of the maternal stroma. Taken from Sharkey 
and Smith, 2003.    
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After implantation, the conceptus undergoes massive growth, due largely to 
the development of extraembryonic membranes.  The formation of these 
membranes is the vital importance in the ability of the embryo to attach in some 
species. In fact the chorioallantoic membrane is the foetal contribution to the 
placenta and will provide the surface for attachments to the endometrium (Senger, 
2005). Regardless of the placental type, the purpose of attachment is to bring 
embryonic tissue and conceptus blood vessels into contact with the maternal blood 
supply to allow nutrient uptake, waste elimination, and gas exchange between the 
mother and the conceptus (Lee & DeMayo, 2004).   
2.2. Bovine pregnancy 
2.2.1. Implantation  
In ruminants implantation takes place when the spherical blastocysts 
elongates to a tubular form, after which the embryo and associated membranes 
begin to adhere strongly to the maternal endometrium (Spencer, et al., 2004; Song, 
et al., 2010)  
2.2.2. Type of placentation  
The bovine placenta is classified as synepitheliochorial (Wooding, 1992). In 
contrast to haemochorial placenta, placentation in the ruminants is characterized 
by multiple discrete areas of attachment, called placentomes, and formed by 
interactions of patches of the chorioallantois with the endometrium (Igwebuike, 
2006).   
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2.2.3. Morphometry and histology of bovine placenta  
The placentome consists of a fetal portion (the cotyledon) contributed by 
the chorion, while the maternal contact sites are the caruncles, originated from 
uterus (Figure 2).   
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Figure 2. Diagrammatic representation of the bovine placentome. The 
cotyledonary tissue is characterized by numerous “button-like” structures 
distributed across the surface of the chorion. The cotyledons (black) fuse with the 
maternal caruncles (gray), and they form a placentome. Source: (Senger, 2005). 
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The formation of placentomes is a ongoing process that begins immediately 
after pregnancy recognition, and the chorion becomes strongly attached to the 
caruncles of the uterus approximately at day 40 of gestation (Leiser & Kaufmann, 
1994; Senger, 2005).  In cows there are between 70 to 120 cotyledons distributed 
across the surface of the chorion, and apparently there is no change in the total 
number of placentomes during gestation (Laven & Peters, 2001). Moreover, the 
cotyledons display a villous interdigitation of fetal villi with maternal crypts of the 
complementary caruncles (Leiser, et al., 1997).  This adhesion of the 
trophectoderm and the endometrial luminal epithelium occurs in caruncular and 
intercaruncular areas of the endometrium. In the trophectoderm, two 
morphological and functional cell population have been identified, these are the 
mononucletae trophoblast cells  and the binucleate trophoblast cells (Igwebuike, 
2006).  Mononucleate trophoblast cells are cuboidal to columnar cells that 
constitute four-fifths of the trophoblast population, and are primarily involved in 
nutrient exchange (Igwebuike, 2006) . On the other hand, mature binucleate cells 
or trophoblast giant cells (TGC) are large cells that contain two nuclei, but the 
presence of mononuclear and trinuclear forms have been also reported (Klisch, et 
al., 1999)(See Figure 3). 
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Figure 3. Cross section of a bovine cotyledon at approximately 90 days of gestation. 
The image shows the different types of trophoblast cells lying in the chorionic villi. 
UTC, uninucleate trophoblast cells, MTGC, mononucleate trophoblast giant cells, 
BTGC, binucleate trophoblast giant cells, TTGC, trinucleate trophoblast giant cells 
(A. Verduzco, unpublished). 
 
 
 
UTC
MTGC
BTGC 
TGC
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2.2.3.1. Bovine Trophoblast Giant Cells  
The trophoblast giant cells represent approximately 20% of the 
trophectoderm and it has been demonstrated that they originate from 
mononucleate trophoblast cells by acytokinetic mitoses (mitoses uncoupled from 
cell division) (Igwebuike, 2006). Moreover the occurrence of trinuclear cells is the 
result of the fusion of binuclear trophoblast cells with uterine epithelial cells 
(Klisch, et al., 1999). The TGCs are believed to be endocrine cells that produce 
factors, which are necessary to mediate gas and micronutrient exchange through 
the placenta and specially to guarantee fetal survival (Wooding, 1992).  These cells 
are the only placental cells that have the capacity to migrate across the feto-
maternal interface to fuse with columnar cells of the maternal uterine epithelium. 
The TGCs have at least two functions: 1. to form a hybrid feto-maternal syncytium 
essential for successful implantation and subsequent placentomal growth; 2. to 
synthesize and secrete protein and steroid hormones as placental lactogen (CSH1) 
and progesterone (P4) (Spencer et al, 2004). Migration and fusion of TGCs with 
maternal endometrial cells are imperative for the delivery of the aforementioned 
factors into the maternal compartment and subsequently to the maternal 
circulation (Senger, 2005; Igwebuike, 2006)(Figure 4).  
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Figure 4. Schematic representation of how binucleate giant cells (BNGC) or 
Trophobast giant cells (TGCs) migrate from the chorion to the endometrial 
epithelium in ruminants. These cells are thought to secrete placental lactogens, 
pregnancy specific proteins and steroid hormones. Source (Senger, 2005). 
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2.2.4. Pregnancy recognition in cattle  
In ruminants the columnar trophoblast cells synthesize and secrete IFNT, 
the pregnancy recognition signal from Days 8 to 24 of gestation.  The effect of the 
IFNT is the maintenance of a functional CL, abrogation of the endometrial luteolytic 
mechanism, and also establishment of uterine receptivity to implantation (Kubisch, 
et al., 2001; Spencer & Bazer, 2004; Bazer, et al., 2009; Farin, et al., 2010). IFNT acts 
directly on the uterine endometrium blocking the expression of estrogen receptor 1 
(ESR1), and therefore indirectly silences oxytocin receptor (OXTR) expression in 
the endometrial epithelium, preventing endometrial prostaglandin F2α (PGF(2α) 
synthesis and release (Walker, et al., 2009; Banu, et al., 2010; Farin, et al., 2010).  
2.2.4.1. Ruminant endometrial receptivity  
Endometrial receptivity is a self-limited period in which the endometrium 
acquires the ability to adhere the developing blastocyst (Dominguez, et al., 2003). 
In bovine, this process involves numerous physiological, molecular and cellular 
interactions between the conceptus, the receptive endometrium, and the corpus 
luteum; which play a pivotal role in establishment of the pregnancy and 
development of the placenta (Hashizume, 2007; Farin, et al., 2010).  
Steroid hormones, cytokines, chemokines, growth factors, IFNT, pregnancy-
associated glycoproteins (PAGs) and chorionic somatomammotropin hormones  
(CSH) secreted by the ovary, endometrium and developing embryo, have been 
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shown to be involved in the coordination of the endometrial receptivity (Adamson, 
1993; Sharkey, 1998; Hashizume, 2007).  
In ruminants the coordinate expression and sequential exposure of the 
pregnant endometrium to P4, IFNT, CSH1, prolactin (PRL) and growth hormone 
(GH), are necessary to activate and maintain endometrial remodeling, secretory 
function, and uterine growth during gestation (Spencer, et al., 1999). In this 
context, IFNT and P4 are essential factors for endometrial receptivity in early 
bovine gestation. Exposure of endometrium to steroid hormones, especially P4 and 
estrogens, prepare the endometrium for implantation and then maintain the 
gestation by promoting uterine growth, modulating the maternal immune system 
and suppressing myometrial contractions (Graham & Clarke, 1997; Sharkey & 
Smith, 2003; Goff, 2004).  
 The primary action of IFNT is to abrogate the pulsatile secretion of PGF(2α), 
blocking the luteolytic mechanism (Bazer, et al., 2009). Moreover recent studies in 
ovine and bovine, indicate that conceptus IFNT also stimulated genes such as 
radical S-adenosyl methionine domain containing 2 (RSAD2), interferon induced 
with helicase C domain 1 (IFIH1),  IFN-stimulated gene 15 (ISG15); which are  
important genes in the establishment of uterine receptivity to implantation, 
conceptus development and modulation of local immune cells in the endometrium 
(Song, et al., 2007; Yang, et al., 2010) .Figure 5 presents the principal pleiotropic 
(producing more than one effect) effects of P4 and IFNT in mammal’s pregnancy. 
In addition to the molecules listed above, other factors and genes such as 
metalloproteinases (MMP8,MMP10,MMP26), integrins, mucins (MUC4,MUC5B), 
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secreted phosphoprotein 1 (SSP1), calcitonin, leukaemia inhibitory factor (LIF), 
homeobox genes (HOXA10 and HOXA11), have been reported essential for uterine 
receptivity in the human and mouse (Lim, et al., 1999; Sharkey & Smith, 2003; 
Altmae, et al., 2010; Casals, et al., 2010; Sendag, et al., 2010). Some of the 
aforementioned molecules have yet proven useful as biomarkers of endometrial 
receptivity (Casals, et al., 2010; Fogle, et al., 2010; Rackow, et al., 2011).  
Although the implantation process is different in bovine compared to human 
and mice; a recent study  points to the potential use of endometrial and embryo 
gene expression patterns as predictors of pregnancy success in cattle (Salilew-
Wondim, et al., 2010). In this study cell division, kinesin, integrins, chemokines, 
insulin growth factors, solute carriers, WD repeats, adapter protein, leucine reach 
repeats, claudins, coiled-coil domain, inositol, ATPases, Zink finger, S100 calcium 
binding protein, collagen families, RNA binding motif, Rho GTPase activating 
protein, CD molecules, keratins, protein kinases and phosphatase gene clusters 
were differentially expressed in embryo biopsies resulting in calf delivery.   
In addition, transcript levels of many new candidate genes involved in the 
regulation of transcription, cell adhesion, modulation of the maternal immune 
system and endometrial remodeling were found to be increased during the 
implantation window (Bauersachs, et al., 2006).However, the precise mechanism 
or mechanisms involved in the ruminant endometrial receptivity have not been 
fully investigated.  
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Figure 5. General pleiotropic effects of progesterone (P4) and interferon-tau (IFNT)on 
conceptus development, pregnancy and maternal well-being in mammal’s pregnancy. 
Uterine luminal epithelium (LE), stromal cells (SC), glandular epithelium (GE), superficial 
glandular epithelum (sGE), cystatin C (CST3), galectin 15; lectin (LGALS15), cathepsin 
L, cysteine proteinase (CTSL) and wingless-type MMTV integration site family, 
member 7A (WNT7A). Source: (Bazer, et al., 2008). 
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2.3. Steroid Biosynthesis  
2.3.1. General aspects  
The synthesis of steroids is a vital process for essential physiologic functions 
such as blood salt balance, carbohydrate metabolism and reproduction. Steroid 
hormones are synthesized predominantly in the adrenal cortex, testis, ovary, 
placenta and central nervous system (Simpson & Waterman, 1983; Hornsby, 1987; 
Payne & Youngblood, 1995; Arensburg, et al., 1999; Pasqualini, 2005; Rekawiecki, 
et al., 2008; Rone, et al., 2009).  The steroids occur in a large diversity of 
biologically active forms; this variety is due partially by steroid-synthesizing 
tissues, depending upon the set of enzymes present in it. Steroids include 
principally: testosterone (androgens), estradiol (estrogen), progesterone 
(progestin), cortisol/corticosterone (glucocorticoid), aldosterone 
(mineralocorticoids), neurosteroids and a wide variety of intermediate metabolites 
(Bogan & Hennebold, 2010).  In general, P4 and estradiol are classified as sex-
steroids, and are produced primarily in ovary and placenta; whereas 
glucocorticoids and mineralocorticoids are produced in adrenal glands, androgens 
in testes, and neurosteroids in brain (Enyeart, 2005; Pasqualini, 2005; Ghayee & 
Auchus, 2007; Mellon, 2007; Rekawiecki, et al., 2008; Lavoie & King, 2009) (Figure 
6) . Although steroid hormones are synthesized with different physiological actions 
in each tissue, their synthesis depends on a common precursor, namely cholesterol 
(Ghayee & Auchus, 2007).   
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Figure 6. Overview of steroidogenesis and the principal steroid hormones. Boxes indicate 
the major tissues for each reaction (adrenal glands, gonads and placenta). Abbreviations 
include DOC (deoxycorticosterone), DHEA (dehydroepiandrosterone), DHEA-S (DHEA 
sulfate), ZF (zona fasciculata), ZR (zona reticularis) and ZG (zona glomerulus).   From 
Lavoie and King, 2009.  
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2.3.2. Cholesterol transport  
In all mammals, cholesterol is an important sterol found in the cell 
membranes, which can be derived from the diet or be synthesized de novo (Bloch, 
1952). It is well known that cholesterol is the starting point for biosynthesis of 
steroids, oxysterols and bile acids in mitochondria (Russell, 2003; Steck & Lange, 
2010).  Cholesterol is transported in the blood plasma to the target tissue as 
lipoproteins (Plosch, et al., 2007). High density lipoproteins (HDL) and low density 
lipoproteins (LDL) are the principal carriers responsible for cholesterol transport. 
The relative contribution of HDL or LDL in cholesterol uptake varies among species 
and tissues. There are two known pathways for cholesterol absorption and import 
into the cell: a non-selective endocytic pathway and a selective absorption 
pathway. In the non-selective pathway, LDL are specifically bound and internalized 
via the LDL family receptors (LDLr); and the receptor fuses with the endosomal 
pathway for distribution of the lipoproteins (Murphy & Silavin, 1989; Argov, et al., 
2004). On the other hand, the selective pathway uses a specific receptor, the 
scavenger receptor class B member I (SCARB1) situated at the plasma membrane 
to bind both LDL and HDL (Hoekstra, et al., 2009; Kolmakova, et al., 2010). The 
selective pathway takes the cholesterol present in the lipoproteins, and it is 
transferred directly to the cell membrane without absorption of the lipoprotein 
particles (Argov, et al., 2004; Steck & Lange, 2010). The mRNA expression of the 
respective receptors for LDLr and scavenger receptor class B member I (SCARB1) 
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was determined in bovine ovarian cells at different stages of follicular development 
(Argov, et al., 2004). 
Once inside the cell the cholesterol esters and triglycerides in the cell can be 
stored in lipid droplets, which are bound by a phospholipid membrane (Rone, et al., 
2009). The stored cholesterol esters present in the lipid droplets are converted to 
free cholesterol. In steroidogenic cells, upon hormonal stimulation there is 
increased cholesterol absorption through the plasma membrane; and cholesterol 
esters are hydrolyzed by lipases, principally hormone-sensitive lipase 
(HSL)(Kraemer & Shen, 2002). HSL interacts with various cholesterol-binding 
proteins to direct the cholesterol to the outer mitochondrial membrane, where the 
first step in the steroidogenic process takes place (Lavoie & King, 2009).   
 
2.3.2.1. Importing cholesterol into the mitochondria  
In the acute steroidogenic response, cells must deliver large amounts of 
cholesterol: from the cytoplasm to the outer mitochondrial membrane, and from 
there to the inner mitochondrial membrane. It is believed that two strategic 
pathways could be the responsible for the movement of cholesterol across aqueous 
cytoplasmic spaces (Soccio & Breslow, 2004; Rone, et al., 2009). In the first “the 
vesicular pathway”, the cholesterol is incorporated into vesicular membranes (e.g. 
lysosomes, endosomes, peroxisomes) which subsequently fuse with other 
membranes, delivering cholesterol into the inner mitochondrial membrane. 
However this route appears to be a minor pathway. On the other hand, in the 
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second route “the non-vesicular pathway”, cholesterol can be solubilized and 
transferred by cholesterol-binding proteins, through the cytosol to the 
mitochondria (Soccio & Breslow, 2004; Rone, et al., 2009).  
Several candidate proteins, including SNARE complexes, vimentin-intermediate 
filaments, nonspecific transporters like sterol carrier protein 2 (SCP2), voltage-
dependent anion channel (VDCA) and a subfamily of lipid binding proteins referred 
to as STARD4, STARD5 and STARD6 have been proposed for the cytoplasmic 
cholesterol transfer to the outer membrane (Bogan & Hennebold, 2010). The 
transfer of cholesterol from the outer to the inner membrane is considered as a 
rate-limiting step in steroid formation; and until now the prototypical 
steroidogenic acute regulatory protein (STAR), is the principal molecule implicated 
in this process. Mutations in STAR protein cause a specific phenotype in 
intracellular cholesterol distribution (lipoid congenital adrenal hyperplasia)(Lin, et 
al., 1995; Sugawara, et al., 1995). Nevertheless studies suggest that STAR proteins 
presumably work in concert with the translocator protein (18 kDa, TSPO) and 
endozepine, which is the natural ligand for TSPO (Niswender, 2002; Papadopoulos, 
et al., 2006; Rone, et al., 2009). Figure 7 illustrates the trafficking of cholesterol to 
the mitochondria for steroidogenesis more precisely.  
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Figure 7. Uptake and transport of cholesterol to the mitochondria for steroidogenesis. Pathway 1 
shows the passive diffusion of cholesterol from the endoplasmic reticulum to the mitochondria, via 
the acyl-CoA binding domain containing (PAP7 or ACBD3) protein. In pathway 2,  low density 
lipoprotein (LDL),binds to the LDLr and  cholesterol is trafficked through the endosomes to the 
mitochondria via the Niemann-Pick type C proteins (NPC) proteins and StAR-related lipid transfer 
(START) domain containing 3 (MLN64) protein. In pathway 3 cholesterol is transported from high 
density lipoprotein (HDL) to the plasma membrane by the SR-BI receptor. In pathway 3 and 4 
hormone-sensitive lipase (HSL) converts esterified cholesterol from the plasma membrane or from 
the lipid droplets in free cholesterol. Finally free cholesterol interacts with lipid-binding proteins 
present in the cytosol for delivery to the mitochondria, where the enzyme cytochrome P450, family 
11 subfamily, A polypeptide 1 (CYP11A1) transforms cholesterol into pregnenolone. Taken from 
(Rone, et al., 2009). 
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2.3.2. Steroidogenic enzymes  
The biosynthesis of steroids involves several enzymes, however all the 
steroid hormones are synthesized through a common precursor steroid, 
pregnenolone (Hu, et al., 2010). In the inner mitochondrial membrane, the enzyme 
CYP11A1 converts the insoluble cholesterol into soluble pregnenolone, by the 
enzymatic cleavage of a 6-carbon side-chain of the 27-carbon cholesterol molecule 
(Ghayee & Auchus, 2007).  Pregnenolone is next metabolized to progesterone by 
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerases 
(HSD3B). HSD3B isoforms are membrane-bound enzymes, which are found in both 
mitochondrial and microsomal membranes, depending on the type of cell.  Their 
enzymatic actions are essential to catalyze the conversion of intermediary 
metabolites into active steroid hormones (see figure 8). The variant isoforms of 
HSD3B are highly homologous in their amino acid sequence, and are specific for 
each species (Lavoie & King, 2009). In humans, two isoforms have been identified: 
HSD3B1 and HSD3B2, and both function as steroid dehydrogenase/isomerases and 
are involved in the biosynthesis of all active steroid hormones (Payne & 
Youngblood, 1995).  Moreover, the isoforms of HSD3B are expressed in a cell and 
tissue-specific manner. HSD3B1 is expressed in placenta, skin and breast tissue, 
whereas HSD3B2 is expressed in adrenal gland, ovary, and testis (Payne & 
Youngblood, 1995; Pasqualini, 2005). In cows, HSD3B1 is present in ovary and 
placenta (Takagi, et al., 2007; Vanselow, et al., 2010).  
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Like HSD3Bs, the hydroxysteroid (17-beta) dehydrogenase enzymes 
(HSD17B) play essential roles in steroidogenesis, catalyzing the final step in the 
biosynthesis of active gonadal steroid hormones, estradiol, and testosterone (see 
figure 8). They are found as either membrane-bound or soluble enzymes and, 
unlike HSD3B, there is very little homology among different HSD17B isozymes 
(Payne & Youngblood, 1995). Among the different forms of human HSD17B, only 
types 1, 3 and 7 participate in the final step of biosynthesis of active steroid 
hormones in gonads (Payne & Youngblood, 1995). In cattle, Cytochrome P450, 
family 17, subfamily A, polypeptide 1 (CYP17A1) is expressed in ovary and 
trophoblast cells (Schuler, et al., 2006; Luo, et al., 2010; Mossa, et al., 2010) 
Further, pregnenolone can also be hydroxylated in certain tissues by 
CYP17A1 to 17-OH-pregnenolone to DHEA (Lavoie & King, 2009). The 
progesterone and 17-OH-pregnenolone are basic steroids, which can be used as 
intermediary metabolites for all other steroid hormones (see figures 6 and 8). 
Table 3 give a general view of the principal steroidogenic proteins and enzymes 
expressed in bovine.  
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Figure 8. Conventional pathways and associated enzymes of steroid biosynthesis. 
Abbreviations include: DHEA dehydroepiandrosterone and DHT 
Dihydrotestosterone.  Taken from Ghayee and Auchus, 2007 with some 
modifications.  
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Table 3. Principal steroidogenic proteins and genes expressed in a different 
number of bovine tissues and cells.   
Protein or 
gene 
Tissue or cells Reference Function
STAR 
 
Gene and 
protein 
 
 
 
 
Gene 
 
 
Gene 
 
 
 
Gene and 
protein 
 
Gene and 
protein 
 
Gene and 
protein 
 
Gene 
 
 
Adrenal medulla and 
cortex of adrenal gland 
Adrenal mitochondria 
Adrenal fasciculata cells 
Adrenocortical cells 
 
Ovarian theca cells 
 
 
Non-luteinizing granulosa 
cells 
 
 
Corpus luteum  
 
 
Adult testes 
 
 
Placenta (260-280 days of 
gestation) 
 
Placentomes during 
gestation and postpartum 
 
(Nishikawa, et al., 1996; Lo, et al., 
1998; Ivell, et al., 2000; Yamazaki, 
et al., 2006) 
 
 
 
(Bao, et al., 1998; Ivell, et al., 
2000; Braw-Tal & Roth, 2005; 
Murayama, et al., 2008) 
 
(Sahmi, et al., 2004) 
 
 
(Hartung, et al., 1995; Pescador, 
et al., 1996; Mamluk, et al., 1999) 
 
(Pilon, et al., 1997; Aspden, et al., 
1998) 
 
(Pescador, et al., 1996; Pilon, et 
al., 1997) 
 
(Takagi, et al., 2007) 
Delivery of cholesterol into the 
mitochondria.  
 
 
 
 
 
 
 
CYP11A1 
 
Gene 
 
 
Gene 
 
Gene and 
protein 
 
 
Gene 
 
 
Gene and 
protein 
 
Gene and 
protein 
 
 
 
Non-luteinizing granulosa 
cells 
 
Ovarian theca cells 
 
 
Fetal adrenal gland 
 
 
Placentomes during 
gestation and postpartum 
 
Placenta (100-280 days of 
gestation) 
 
 
Adult testes 
 
 
(Sahmi, et al., 2004) 
 
 
(Mamluk, et al., 1999; Murayama, 
et al., 2008) 
 
(Conley, et al., 1992) 
 
 
(Takagi, et al., 2007) 
 
 
(Conley, et al., 1992) 
 
 
 
(Aspden, et al., 1998) 
 
Conversion of cholesterol to 
pregnenolone 
HSD3B1 
 
Gene and 
protein 
 
 
 
 
Fetal adrenal 
 
 
 
 
(Conley, et al., 1992) 
 
 
 
Conversion of pregnenolone to 
progesterone 
 
 
35 
 
Gene 
 
 
Gene 
 
Enzymatic 
activity by 
substrate 
metabolism 
 
Gene and 
protein 
 
Gene 
 
Gene and 
protein 
 
Non-luteinizing granulosa
cells 
 
Theca cells 
 
Caruncles and cotyledons 
(120-280 days of 
gestation) 
 
Placenta (100-280 days of 
gestation) 
 
Placentomes during 
gestation and postpartum 
 
Adult testes 
 
(Sahmi, et al., 2004)
 
 
(Murayama, et al., 2008) 
 
(Tsumagari, et al., 1994) 
 
 
 
(Conley, et al., 1992) 
 
 
(Takagi, et al., 2007) 
 
 
(Aspden, et al., 1998) 
CYP17A1 
 
Gene and 
protein  
 
 
Gene and 
protein  
 
Gene and 
protein 
 
Gene and 
protein 
 
 
Placentomes from 
pregnant (days 80-284), 
prepartal and parturient 
period. 
 
Fetal adrenal 
 
 
Adult testes  
 
 
Adrenocortical cells 
 
(Conley, et al., 1992; Schuler, et 
al., 2006) 
 
 
(Conley, et al., 1992) 
 
 
(Aspden, et al., 1998) 
 
 
(McCarthy, et al., 1983; Zuber, et 
al., 1985) 
Catalysed androgen synthesis 
 
 
CYP19A1 
 
Gene 
 
Gene 
 
Gene and 
protein  
 
 
 
 
Granulosa cells 
 
Theca cells 
 
Placentomes from 
pregnant (days 80-284), 
prepartal and parturient 
period. 
 
 
(Vanselow, et al., 2001) 
 
(Luo, et al., 2010) 
 
(Schuler, et al., 2006) 
Conversion of androgens into 
oestrogens 
 
SULT1E1 
 
Gene 
 
 
Gene 
 
 
Villi and caruncle (Day 25-
250 of gestation) 
 
Caruncular and 
cotyledonary tissue at 
parturition 
 
(Ushizawa, et al., 2007) 
 
 
(Hirayama, et al., 2008) 
Sulfation of estrogens 
 
 
 
 
STS 
 
Gene 
 
 
Caruncular and 
cotyledonary tissue at 
parturition 
 
 
(Hirayama, et al., 2008) 
Conversion of sulfoconjugated 
estrogens into estrogens 
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2.3.3. Estrogen sulfoconjugation  
The activity of estrogens is regulated by sulfoconjugation that controls the 
availability of free estrogens. The sulfotransferase family 1E, estrogen-preferring, 
member 1 (SULT1E1) is a cytosolic enzyme with high affinity for estrogens, 
especially for estradiol; and its presence have been reported in testis, pregnant 
uterus and placenta of murine (Qian, et al., 2001; Takehara, et al., 2001; Luu-The, et 
al., 2005; Pasqualini, 2005). SULT1E1 catalyzes the sulfation of estrogens at the 3-
hydroxyl position, changing them from hydrophobic to hydrophilic molecules, and 
the estrone sulfate (E1S) is the principal inactive form of estrogen catalyzed by this 
enzyme  (Song, 2001). Sulfation inhibits the binding of steroids to their nuclear 
receptors, and these conjugates represent a local reservoir of the hormone after 
hydrolysis. E1Ss may serve as substrates for the formation of biologically active 
estrogens via the action of steroid sulfatase (STS) (Reed, et al., 2005). STS is a 
member of sulfatase enzymes, and has been found in steroidogenic (testis, ovary, 
adrenal glands, endometrium, brain and placenta), non-steroidogenic tissues, and 
as well in physiological processes and pathological conditions (Reed, et al., 2005; 
Suzuki, et al., 2007). STS is responsible for the hydrolysis of estrone sulfate and 
HSD17B1 
 
Gene 
 
 
 
Granulosa cells 
 
(Zheng, et al., 2008) 
Catalyzes the conversion of 
estrone to estradiol 
 
 
HSD17B1 
 
Gene 
 
 
 
Granulosa cells 
 
(Zheng, et al., 2008) 
Oxidizes or reduces estrogens and 
androgens 
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dehydroepiandrosterone sulfate to estrone and dehydroepiandrosterone 
respectively; both of which subsequently can be converted in active steroids 
(estradiol and androstenediol) (Reed, et al., 2005). In conclusion, it seems that 
SULT1E1 and STS work together regulating the activity and the availability of 
active and inactive estrogens. 
2.3.4. Regulation of steroidogenesis and principal steroidogenic pathways  
The acute and chronic production of steroids is controlled principally by 
trophic hormones (LH, FSH or ACTH) and occurs in the order of minutes and hours 
(Stocco, et al., 2005). The principal trophic hormones that stimulate 
steroidogenesis are: the adrenocorticotropic hormone (ACTH) in adrenocortical 
and adrenal fasciculata cells, and LH and follicle-stimulating hormone (FSH) in 
gonads (Nishikawa, et al., 1996; Sekar, et al., 2000; Rekawiecki, et al., 2005; Wang, 
et al., 2009).  
During acute hormonal stimulation, a rapid mobilization and transport of 
cholesterol reserves of cholesterol to mitochondria is followed by a rapid synthesis 
of new steroids by abovementioned steroidogenic proteins and enzymes (Stocco, 
2000). Trophic hormones bind to their respective G protein coupled receptors, thus 
leading, in most cases, to activation of adenylate cyclase, which turn on the cyclic-
AMP (cAMP) dependent protein kinase pathway, protein kinase A (PKA), and in the 
activation of steroidogenic proteins as STAR, CYP11A1, and HSD3B, among others, 
(Hu, et al., 2010).  
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LH receptors in bovine CL are located principally in small luteal cells 
(Okuda, et al., 1999). Binding of LH to its receptor, leads to cAMP dependent PKA 
pathway activation, and a subsequent increase in P4 production (Rekawiecki, et al., 
2008). Moreover LH stimulates Leydig cell testosterone synthesis via cAMP-PKA 
dependent pathway (Lavoie & King, 2009).  In bovine and primate CLs, LH 
increases the expression and synthesis of the three principal steroidogenic markers 
(STAR, CYP11A1 and HSD3B) (Ravindranath, et al., 1992; Rekawiecki, et al., 2005). 
However extensive evidence indicates that trophic hormones can also trigger other 
second messenger systems. In this respect, in bovine adrenal fasciculata-reticularis 
cells, ACTH enhances expression of the STAR protein via the cAMP-dependent PKA 
and protein kinase C (PKC) signaling pathways (Nishikawa, et al., 1996; Morley, et 
al., 2000). Furthermore, it was reported that in fasciculata cells, calcium (Ca2+) 
stimulates the expression of STAR, and it is essential for ACTH action on 
corticoidogenesis (Morley, et al., 2000; Yamazaki, et al., 2006).  
It has been found that activation of extracellular-signal-regulated kinases 
(ERK)/mitogen activated protein kinase (MAPK) and phosphoinositide 3-kinases  
(P13K) /Akt pathways, modulate the synthesis of steroids in bovine granulosa and 
theca cells (Tajima, et al., 2005; Fukuda, et al., 2009). Few studies have addressed 
the principal intracellular pathways implicated in the synthesis of steroidogenic 
genes and hormone synthesis. In primary cultures of human placental tissue and 
trophoblast cells, analogues of cAMP stimulate CYP11A1 mRNA and P4 production 
(Chung, et al., 1986; Ringler, et al., 1989). Conversely, CY11A1 gene regulation in 
rodent placenta is cAMP independent (Matt, et al., 1986; Sher, et al., 2007). 
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However, other hormones and factors can also stimulate secretion of 
steroids in gonads and adrenal glands. In this respect, Rekawiecki et al (2005), 
found a stimulatory effect of prostaglandin E(2) (PGE(2)) and progesterone on 
StAR, CYP11A1 and HSD3B1 gene expression in bovine luteal cells. Moreover, 
previous studies documented a significant role of Ca2+, stimulating the expression 
of STAR in adrenal cells (Cherradi & Capponi, 1998; Yamazaki, et al., 2006).  In 
concert with the aforementioned factors, insulin or IGF-I in combination with LH 
regulated the STAR gene expression in porcine granulosa-luteal cells (Sekar, et al., 
2000). It was also demonstrated that MA-10 Leydig cells possess highly specific 
and biologically functional prolactin receptors (PRLR) mediating direct and dose-
dependent biphasic effects of PRL on hCG-induced progesterone secretion (Weiss-
Messer, et al., 1996). In addition, activated macrophages synthesize pro-
inflammatory cytokines such as interleukin-1 (IL-1) and tumor necrosis factor 
(TNF) that are extremely inhibitory to Leydig cells and appear to act as 
transcriptional repressors of STAR gene expression (Hales, 2002). 
Apparently, placental regulation of steroidogenic genes varies between 
tissues and species, reflecting in part the placental diversity and placental steroid 
function in viviparous animals.   
2.4. Steroids synthesis during pregnancy  
2.4.1. General aspects  
During gestation, the steroid hormones, in particular progesterone and 
estrogens, have important roles in regulating key physiological events such as: 
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maternal recognition, endometrial receptivity, maintenance of pregnancy, 
development of glandular tissue and early embryonic development (Graham & 
Clarke, 1997). As mentioned before, steroidogenesis in the gonads and adrenal 
glands is predominantly mediated through the interaction of LH, FSH and ACTH. 
However, there is no report describing the principal intracellular pathways and 
factors implicated in the regulation of the steroidogenic process in the bovine 
placenta. 
2.4.2. Cholestrol uptake in placenta  
Cholesterol plays and essential role in mammalian embryonic development 
to sustain the rapid growth of the placental and fetal tissues, as well as substrate 
for steroidogenesis (Pepe & Albrecht, 1995; Plosch, et al., 2007).   
In human, de novo synthesis of cholesterol is limited, and cholesterol is 
obtained principally from plasma low density lipoprotein (Furuhashi, et al., 1989). 
As we mentioned before (section 2.3.2.1) cholesterol delivery from LDL is mediated 
by receptor-mediated uptake. In this respect human placenta is able to bind and 
internalize maternal lipoproteins (Alsat, et al., 1984; Alsat, et al., 1985).  
HDL and LDL receptors are expressed in placenta specially at the villous 
trophoblast and syncytiotrophoblast membrane of rodents and humans; suggesting 
that the presence of these receptors could serve as an efficient route for 
lipoproteins transfer from the maternal to foetal tissues (Alsat & Malassine, 1991; 
Bonet, et al., 1995; Wadsack, et al., 2003; Ethier-Chiasson, et al., 2007; Watanabe, et 
al., 2010).  However the precise mechanism of the uptake of cholesterol in placenta 
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remains to be elucidated. Moreover the presence of the aforementioned 
lipoproteins receptors in bovine placenta has not been studied.   
2.5. Steroids synthesis in bovine placenta 
2.5.1. Placental production of progesterone and estrogens in cattle  
In cattle, as in many mammalian species, the placenta produces large 
amounts of steroids, mainly P4, estrone (E1) and E2 (Hoffmann, et al., 1997; Wood, 
1999). But in contrast to other species, where the placenta adopts the role as the 
main source of progestagens, the CL is the principal source of P4 during gestation, 
and the placenta does supplement during the third trimester of gestation 
(Hoffmann & Schuler, 2002). Lutectomy or luteolysis in the cow before day 210 of 
gestation results in abortion (Day, 1977; Chew, et al., 1979; Johnson, et al., 1981). It 
would appear that the bovine feto-placental unit generates steroids that reach in 
the peripheral circulation during the bovine gestation (Gabai, et al., 2004). 
However, concentrations of P4 in bovine placental tissue increase considerably 
within the fifth and sixth month of gestation, reaching maximal values in the 
cotyledons in the eighth and ninth month (Tsumagari, et al., 1994). It must 
nevertheless be considered that, apart from acting as classical endocrine hormones, 
sex steroids may also function as autocrine or paracrine regulators, as has been 
demonstrated in testis and ovary (Zirkin, 1998; Schuler, et al., 1999; Slomczynska & 
Wozniak, 2001). The presence of both estrogen and progesterone receptors in the 
caruncular and cotyledonary tissues suggest a functional role for local steroid 
production in the bovine placenta (Hoffmann & Schuler, 2002; Schuler, et al., 2005).  
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In addition, there are numerous studies of bovine gestation detailing the synthesis 
of P4, E2 and E1 by TGC and UTC cell cultures (Reimers, et al., 1985; Wango, et al., 
1991; Matamoros, et al., 1994). P4 is synthesized by bovine maternal caruncular 
cells in a pattern where it was low or undetectable in the first trimester, but 
increased more than 10-fold in the second trimester of gestation (Shemesh, et al., 
1992). 
Despite the fact that bovine placental cells produce steroid hormones, 
localization of most of the enzymes and non-enzymatic proteins that are required 
for the steroid hormone synthesis has not been well investigated. Studies so far are 
limited to demonstration of the presence of enzymes needed for the production of 
steroids (STAR, CYP11A1, CYP17A1, HSD3B1 and SULT1E1) in bovine trophoblast 
and in caruncular tissue (Nash, et al., 1988; Tsumagari, et al., 1994; Pescador, et al., 
1996; Hoffmann, et al., 2001; Takagi, et al., 2007; Schuler, et al., 2008).  Although 
the role of placental steroid hormones in the progression of gestation in ruminants 
remains indistinct, steroids are known to exert their effect primarily through their 
cognate nuclear receptors, estradiol receptor 1 (E2R1) and progesterone receptor 
(PGR), producing paracrine factors that could regulate proliferation and/or 
differentiated functions of glandular epithelium and, to some extent, endometrial 
luminal epithelium during pregnancy (Schuler, et al., 2002; Spencer, et al., 2004).  
Moreover, recent information indicates that placental progestagens could regulate 
caruncular development, while estrogens could serve as paracrine inducers of 
differentiation of the fetal trophoblast giant cells (Hoffmann & Schuler, 2002; 
Schuler, et al., 2008). It was also suggested that bovine UTCs and TGCs exhibit 
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different steroidogenic capacities constituting a ‘two-cell’ organization for estrogen 
synthesis. The aforementioned is based on the fact that CYP17A1 expression 
appears to be quickly down-regulated and cytochrome P450, family 19, subfamily 
A, polypeptide 1 (CYP19A1) is up-regulated when UTCs enter the TGCs 
differentiation pathway (Schuler, et al., 2006). However, most of the 
aforementioned studies were conducted in advanced gestations. Thus the question 
for the biological need of steroids production and the expression of steroidogenic 
factors during early bovine gestation still arises. What is more, the exact 
steroidogenic homing mechanism and the principal cells implicated in this process 
in the progression of bovine gestation are not clearly understood.   
2.5.2. Bovine steroids and parturition  
In addition to the role of P4 and E2 in the progression of gestation, steroids are key 
factors in the complex cascade of physiologic events in parturition. It is well 
documented that a considerable increase in E1 and E2, during the periparturient 
period are necessary in the labor and delivery process (Hoffmann, et al., 1997; 
Wood, 1999; Senger, 2005). Progesterone promotes myometrial relaxation; and 
estrogens augment myometrial contractility and excitability (Mesiano & Welsh, 
2007). Thus a balance between these two hormones it’s pivotal in the parturition 
process. Limited information exist about the precise mechanism in the parturition 
process, however  it seems very clear that the withdrawal of progesterone is a 
prerequisite for the uterus to proceed with contraction during parturition (Kindahl, 
et al., 2004) (Figure 9). 
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Figure 9.  Estrone (E1), estradiol (E2) and progesterone (P4) profiles during 
gestation in the cow. Taken from Senger, 2005 with some modifications.  
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2.5.3. Estrogen sulfoconjugation in bovine placenta  
To date, studies have demonstrated the presence of STS and SULT1E1 
enzymes in bovine placenta (Brown, et al., 1987; Nash, et al., 1988; Janszen, et al., 
1995; Hoffmann, et al., 2001; Ushizawa, et al., 2007). It is well known that these 
enzymes play an essential role regulating the availability of free estrogens.  In 
human placentas, estrogens are formed using fetal and maternal precursors; and 
most of them circulate in fetal compartment as sulfates. A substantial exchange 
between the placenta unconjugated estrogens (hydrolysis) and fetal estrogen 
sulfates in a constant way, has a great biological significance.  
The estrogen sulfates may act as an estrogen store, yielding active hormones 
following hydrolysis; but also controlling the availability of free and active 
estrogens by the formation of estrogen sulfates (hormonally inactive) (Pasqualini, 
2005).  E1S has been shown to be a very important parameter of fetoplacental 
function and placental viability in bovine gestation. (Zhang, et al., 1999; Isobe, et al., 
2003; Shah, et al., 2007). The aforementioned is reinforced by the fact that E1S 
levels are correlated positively with calf birth weight and some placental 
characteristics (Zhang, et al., 1999; Kindahl, et al., 2004). Furthermore, 
perturbations in E1S levels may be related to dystocia, retained placenta and small 
stillborn calves (Isobe, et al., 2003; Kornmatitsuk, et al., 2003; Kindahl, et al., 2004). 
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In the bovine placenta E1S is secreted in cotyledons, and can be detected as 
a major conjugated estrogen in the maternal circulation and milk (Zhang, et al., 
1999; Shah, et al., 2007). Conversely, considerable STS activity has been previously 
detected in bovine caruncles (Greven, et al., 2007). The distribution pattern of 
SULT1E1 and STS enzymes in bovine placenta, points to the existence of a local 
regulatory system tightly controlling the availability of free, active estrogens in 
bovine placentomes.   
2.6. Calcium  
2.6.1. General aspects  
Every cell of the body is dependent on the presence of ionic Ca2+ for all 
cellular homeostasis and function and in a variety of structural and functional roles.  
Ca2+ absorption takes place in epithelia of different tissues, including the intestine, 
kidney, mammary glands, adrenal glands and placenta. The Ca2+ transport is 
regulated by a multifarious array of processes that are mediated by hormonal, 
developmental, and physiological factors (Khanal & Nemere, 2008). Ca2+ is required 
for skeletal formation, neuromuscular activities, and blood coagulation 
(Hershberger & Tuan, 1998). 
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2.6.2. Calcium and bovine placenta  
During pregnancy Ca2+ absorption is enhanced, and the placenta transports 
calcium ions actively from mother to fetus against a concentration gradient, 
rendering the fetus relatively hypercalcemic (Pitkin, 1975; Pitkin, 1983; Pitkin, 
1985). The requirements of the fetus for Ca2+ increase progressively throughout 
pregnancy and particularly in late gestation. In late gestation the sheep fetus 
requires 3 g of Ca2+ per day (Wooding, et al., 1996). Thus, the placenta represents 
the principal site of regulation of fetal Ca2+ homeostasis. In the human placenta Ca2+ 
uptake into the trophoblast occurs across the maternal microvillous plasma 
membrane; and subsequently the Ca2+ is translocated from the trophoblast cells to 
the fetal basal plasma membrane, where it can now enter to the fetal circulation 
(Belkacemi, et al., 2003). In addition, Ca2+ influx into the  placenta apparently is 
mediated by a facilitated diffusion process employing Ca2+ binding proteins known 
as the calbindins (Ca2 +BPs) (Belkacemi, et al., 2003). The principal Ca2+BPs that 
have been reported were: a 57-kDa Ca2+BP for mouse placenta; and a calbindin-
D9k (Ca2+BP9k) for human placenta (Hershberger & Tuan, 1998; Belkacemi, et al., 
2003). In this regard, one study demonstrated the expression of Ca2+BP9k in the 
ovine, bovine and caprine placenta. Moreover this study detected the presence of 
this protein only in the columnar trophoblast cells in sheep and goat (Wooding, et 
al., 1996). This supports the notion that Ca2+BP9k mediates the high calcium flux by 
facilitated diffusion. 
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2.6.2.1. Calcium and placental steroidogenesis  
Studies have pointed the Ca2+ as key mediator of placental steroid hormone 
synthesis by cyclic nucleotide independent mechanism (Shemesh, et al., 1988; 
Weems, et al., 2004).  The ionophore A23187 is a Ca2+ analogue enhanced 
progesterone formation (Shemesh, et al., 1988; Weems, et al., 2004). Apparently 
Ca2+ affects mechanisms regulating bovine placental steroidogenesis by stimulating 
the enzyme CYP11A1 and the PKC pathway (Shalem, et al., 1988). In ovine 
chorionic cells, modulation of P4 secretion is modulated by Ca2+, calmodulin and 
protein kinase C (PKC) activators (de la Llosa-Hermier, et al., 1991). Moreover in 
adrenal glands, Ca2+ appears to exert an effect at the intramitochondrial and 
nuclear level, where it activates transcript of steroidogenic acute regulatory 
protein (STAR)(Cherradi & Capponi, 1998). Furthermore in bovine adrenal 
fasciculata–reticularis cells, the dominant second messenger for the stimulation of 
STAR protein expression is Ca2+ (Yamazaki, et al., 2006). However the exact 
mechanisms and factors involved in Ca2+ activatory and activation pathways in 
bovine placenta are still obscure.  
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2.7. SCNT pregnancies  
2.7.1. General aspects  
Over the last decade, a number of species, from farm animals to rodents, 
have been cloned using the SCNT technology by which the nucleus of a somatic or 
differentiated cell is introduced into an enucleated oocyte, and the reconstructed 
oocyte is artificially activated, allowing for nuclear reprogramming to occur. Then 
at the blastocyst stage, the cloned embryo is transferred to a surrogate mother, 
allowing the development of the reconstructed embryo into a genetic clone of the 
animal from which the donor cell was derived (Ross & Cibelli, 2010).   
2.7.2. Bovine SCNT pregnancies  
The several potential applications of bovine cloning include the generation 
of homogeneous animal models for experimental purposes, preservation of 
endangered breeds, multiplication of specific phenotypes, transgenic animals for 
therapeutic, bio-medicine or for improved animal production, and replication of 
valuable genitors (Heyman, 2005).  
 
2.7.2.1. Poor efficiency and alterations  
Although the most frequent species used for somatic cloning is the cow, the 
number of births per number of embryos transferred is still low (0-12%)  (Wells, et 
al., 1999; Wells, et al., 2004; Panarace, et al., 2007; Keefer, 2008). This poor 
efficiency is associated with pre- and postnatal anomalies, including atypical 
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vascularisation of extra embryonic tissue, abnormal placenta development, 
prolonged gestation, oversized calves, musculoskeletal deformities, respiratory 
distress, cardiopathology and abnormal kidneys as well as hypertrophic liver 
(Cibelli, et al., 1998; Hill, et al., 2000; Bertolini & Anderson, 2002; Chavatte-Palmer, 
et al., 2002; Lee, et al., 2004).  However, a high rate of fetal loss occurs during peri- 
implantation period and between days 30 and 90 of gestation, which in most cases 
are associated with anomalies in feto-placental unit (Cibelli, et al., 1998; Hill, et al., 
2000; Pace, et al., 2002).  
 
2.7.2.2. Abnormal placental and fetal development  
Abnormal placentation in SCNT bovine gestations is often associated with 
poorly developed placentomes, hypertrophy and fewer cotyledons, increase in 
caruncular weight, severe edema of the intercotyledonary placental membranes 
and detachment of placental membranes (Hill, et al., 2000; Hashizume, et al., 2002; 
Edwards, et al., 2003; Lee, et al., 2004). In addition, many authors have reported 
abnormal vascularisation of extra-embryonic tissue, lack of placental vascular 
development, hydrallantois, edematous chorioallantoic membranes, reduced 
epithelium at the endometrial trophoblast interface, underdeveloped vasculature 
and a reduced number of TGC (Arnold, et al., 2006; Constant, et al., 2006; Miglino, et 
al., 2007; Kohan-Ghadr, et al., 2008; Palmieri, et al., 2008).  
 
 
51 
 
2.7.2.3. Possible alterations in hormones and factors  
Modifications in some factors that promote placental and vascular 
development have been suggested as possible causes of SCNT failures (Palmieri, et 
al., 2008).  Recent studies have found alterations in the expression of cytokines 
such as:  IGF1, insulin-like growth factor binding protein 1 (IGFBP1) and 
transforming growth factor, beta 1  (TGFB1) in placenta from bovine SCNT 
pregnancies (Ravelich, et al., 2004; Hwang, et al., 2009). In this regard, it is well 
known that cytokines, in particular, members of the TGFB family and members of 
the IGF family are important factors in determining nutrient partitioning between 
the fetus and the placenta to promote fetal growth, cellular mitosis and 
differentiation, cell migration, as well as inhibition of apoptosis  (Bauer, et al., 1998; 
Han & Carter, 2000). In addition, some studies have reported alteration in some 
angiogenic factors as VEGFA, hypoxia inducible factor 1, alpha subunit (HIF1A), 
angiopoietin 1 (ANGPT1), placental growth factor (PGF) and fibroblast growth 
factor 2 (basic) (FGF2) in maternal and embryonic placental tissues from ruminant 
SCNT gestations (Hoffert-Goeres, et al., 2007; Campos, et al., 2010). Thus, variations 
in the expression of the aforementioned factors in cloned pregnancies could have a 
range of effects on fetal growth, placental development and placental 
neovascularization.  
Moreover, Hwang et al. (2009) studying delayed parturition in SCNT 
pregnancies, detected decreased levels of  E2; and elevated levels of TGFB1 and P4 
in plasma from SCNT pregnancies compared to the control group. These authors 
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suggest that delayed parturition in clone calving may be caused by the dysfunction 
of placentomes and aberrant expressions of steroid hormones and cytokines. In 
addition to the systemic alterations of above-mentioned hormones, excess of 
estrogen sulfoconjugation has been found in SCNT during the pre-partum period; 
and apparently this hormonal imbalance contributes to the lack of overt signs of 
readiness for parturition in clone pregnancies (Hirayama, et al., 2008). 
2.7.2.4. Abnormal expression of genes and transcription factors  
In general, many of the defects in cloned embryos are attributed to 
problems with the reprogramming of a nucleus derived from a differentiated cell. 
Reprogramming involves changes in the patterns of epigenetic marks, such as DNA 
methylation and histone modifications, and abnormal patterns of these 
modifications have been reported in cloned embryos (Dean, et al., 2001; Dean, et 
al., 2003; Shi, et al., 2003; Yang, et al., 2007). Many of these modifications occur in 
the later reprogramming, and could affect early placental growth and embryo 
development, through their influence on gene expression especially on imprinted 
genes. Consequently, long-term effects from gene modifications would manifest 
through the progression of gestation, parturition and so forth, in a variety of 
placental and fetal anomalies (Smith & Murphy, 2004; Jincho, et al., 2008; Couldrey 
& Lee, 2010).   
In this regard, a number of studies have undertaken to characterize 
abnormal imprinted gene expression in blastocysts and fetal and placental tissues 
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in SCNT gestations.  These studies found altered abundance of achaete-scute 
complex-like protein 2 (mash2), heart and neural crest derivatives expressed 1 
(HAND1), PAGs and PHLDA2, which are critical genes in trophoblast 
differentiation, proliferation and cell function, in bovine SCNT pregnancies (Arnold, 
et al., 2006; Guillomot, et al., 2010). Similarly, alteration in DNA methylation 
pattern on allelic expression of maternally imprinted gene small nuclear 
ribonucleoprotein polypeptide N (SNRPN) in preimplantation SCNT bovine 
embryos has been reported (Suzuki, et al., 2009).  
Although dysfunctional imprinted and non-imprinted genes may be 
associated with high rates of fetal loss and abnormal development of the fetus and 
placenta in SCNT pregnancies, deeper understanding of epigenetic reprogramming 
will be needed for outlining the molecular mechanisms underlying successful 
bovine cloning.  
2.8. Problem, hypothesis and objectives  
The placenta represents a unique organ of the feto-maternal unit and plays a 
pivotal role in the development and maintenance of pregnancy. In many animal 
species, including the cow, the placenta produces steroid hormones, principally 
estrogens, pregnenolone, progesterone and cortisol (Linzell & Heap, 1968; Challis 
& Patrick, 1981; Matamoros, et al., 1994; Ben-Zimra, et al., 2002; Lia, et al., 2005). 
As mentioned in the literature review, steroid hormones, especially progesterone, 
are unequivocally required for establishment and maintenance of pregnancy, as 
well as maternal support of conceptus survival and development.  
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Studies in vitro have demonstrated that bovine placenta produces steroids, 
and also is a target for steroid action (Shemesh, et al., 1992; Hoffmann & Schuler, 
2002; Schuler, et al., 2005; Schuler, et al., 2008). However, the biological role of 
placental steroids and the principal target cells in bovine gestations remain 
unclear; so far very little is known about the onset of placental steroid production.  
Therefore, the objectives of the first chapter, here included were: 
• Determine the occurrence of candidate proteins (STAR, CYP11A1 and 
HSD3B1), involved in bovine placental steroidogenesis. 
• Identify the principal cells implicated in the steroidogenic protein 
expression through the first third of pregnancy. 
The presence of progesterone and estrogen receptors in placenta clearly 
point to a role of placental steroids as local regulators of placental growth, 
differentiation and functions in cattle (Schuler, et al., 1999; Schuler, et al., 2002; 
Schuler, et al., 2005).  A reduced capacity to synthesize steroids, is not only 
associated with implantation failure and miscarriage but also may contribute to 
abnormal placental and fetal development (Day, 1977; Chew, et al., 1979; Johnson, 
et al., 1981; Mann, et al., 1999; Daya, 2009).  
We therefore hypothesize that placental failure in bovine cloned pregnancies may 
originate from dysfunction of placentomes as a result of aberrant expression of the 
principal steroidogenic proteins and genes. Thus, the objectives of the second 
chapter were:  
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• To characterize the patterns of expression of mRNA and protein of 
some of the main steroidogenic factors (SCARB1, STAR, CYP11A1, HSD3B1, 
CYP17A1, STS and SULT1E1) in SCNT and AI early bovine placentas. 
• To evaluate the expression of key steroidogenic factors (SCARB1, 
CYP11A1 and CYP17A1) in early normal pregnancies 
Finally, although the regulation of steroidogenic proteins and enzymes have 
been studied extensively in the gonads and adrenal glands  (Nishikawa, et al., 1996; 
Aspden, et al., 1998; Ivell, et al., 2000; Nishimura, et al., 2004; Rekawiecki, et al., 
2005; Fukuda, et al., 2009), further research is needed to better understand the 
principal intracellular pathways and factors implicated in the regulation of the 
steroidogenic process in bovine placenta. In view of this statement, the objectives 
of the third chapter were: 
• To develop a bovine placenta explant model to study the synthesis of 
progesterone in the feto-maternal unit (placentome). 
• To assess whether hCG and multiple second messenger systems 
(dbcAMP, PMA and calcium ionophore) regulate the synthesis of 
progesterone in bovine placenta. 
• To investigate the influence of the aforementioned factors upon the 
expression of genes (STAR, CYP11A1, HSD3B1, SULT1E1 and STS) implicated 
in the synthesis of steroid hormones in bovine placenta. 
  
 
 
 
 
MATERIALS, METHODS AND RESULTS 
 
  
 
 
 
 
CHAPTER 3. FIRST ARTICLE 
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3.1. Abstract 
The aim of the present study was to determine the occurrence and localization of 
the principal steroidogenic proteins in bovine placenta from day 50 to day 120 of 
pregnancy.  Immunohistochemistry revealed that, at all stages investigated, bovine 
steroidogenic acute regulatory protein (STAR) and cytochrome P450, family 11, 
subfamily A, polypeptide 1 (CYP11A1) proteins were found in the chorionic plate 
(CP) and in the feto-maternal interdigitations:  chorionic villi (CV) and maternal 
septum (MS). Moreover, uninucleated trophoblast cells (UTCs), stromal cells from 
chorionic villous tree, caruncular epithelial cells (CECs) and caruncular stromal 
cells (CSCs) were the principal cells detected by both markers.  Immunoblot results 
showed a complementary pattern of STAR protein expression between caruncles 
and cotyledons. The protein level of hydroxy-delta-5-steroid dehydrogenase, 3 
beta- and steroid delta-isomerase 1 (HSD3B1) were higher on the caruncle. In 
contrast HSD3B1 mRNA expression was more abundant in cotyledon. Thus suggest 
the existence of HSD3B1 posttranscriptional regulation. The protein results indicate 
that caruncular tissue expresses all three steroidogenic markers, suggesting a 
greater steroidogenic capacity than cotyledons.  The variation in expression of 
steroidogenic proteins between caruncular and cotyledon tissue across gestation in 
a complementary pattern, indicates that placental steroidogenesis requires cell to 
cell communication between the maternal and fetal cells.  
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3.2. Introduction 
Proper progression of feto-maternal developmental interactions is critical 
for positive signalling of maternal recognition of pregnancy, while appropriate 
placental development is key to maintenance of successful gestation. In many 
species, the placenta produces steroid hormones, principally estrogens, 
pregnenolone, progesterone and cortisol, and these play important functions in the 
establishment and maintenance of pregnancy (Linzell and Heap 1968; Challis and 
Patrick 1981; Matamoros, Caamano et al. 1994; Ben-Zimra, Koler et al. 2002; Lia, 
Isomaaa et al. 2005).  The contribution of the placenta to gestation varies among 
species. In swine (Nara, Darmadja et al. 1981) and mink (Douglas, Song et al. 1997) 
the ovaries are entirely responsible of the steroid support of gestation.  In sheep, 
successful pregnancy and parturition can occur in spite of ovariectomy performed 
as early as 50 days into gestation (Weems, Vincent et al. 1992; Campbell, Hallford 
et al. 1994).  Studies in pregnant cows have shown that the corpus luteum is not 
required during the final 70 days of the pregnancy (Day 1977; Chew, Erb et al. 
1979).  These studies indicate that, in ruminants, placental steroid synthesis 
contributes to, and, in some cases, can support gestation.  It has previously been 
demonstrated that the bovine placenta produces steroids, and is a target for steroid 
action, based on the presence of progesterone and estrogen receptors (Shemesh, 
Izhar et al. 1992; Hoffmann and Schuler 2002; Schuler, Teichmann et al. 2005; 
Schuler, Greven et al. 2008).  Further, it would appear that the bovine feto-placental 
unit generates steroids that reach the peripheral circulation during gestation 
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(Gabai, Marinelli et al. 2004). Schuler et al. (2008) have proposed that placental 
progestagens regulate caruncular development, while estrogens serve as paracrine 
inducers of differentiation of the fetal trophoblast giant cells.  
Steroid hormone synthesis requires a cascade of enzymes and some non-
enzymatic proteins. An early step is the transfer of cholesterol into the 
mitochondrion, and the principal agent that has been implicated in this process is 
STAR (Miller 2007). STAR is a mitochondrial protein that is rapidly synthesized in 
response to steroidogenic stimulation. It has been found in most of steroidogenic 
tissues, including the adrenal cortex, the gonads, and the placenta as well as in the 
brain of several species (Pescador, Soumano et al. 1996; Pilon, Daneau et al. 1997; 
Nicol, Wang et al. 1998; Arensburg, Payne et al. 1999; Kim, Kang et al. 2004).  The 
mechanism of action of STAR is not entirely understood (Manna, Dyson et al. 2009) 
but it appears that STAR interacts with other molecules such as the sterol carrier 
protein 2 (SCP2), steroidogenic activator polypeptide (SAP) and the outer 
mitochondrial membrane translocator protein (TSPO), to mediate the transfer of 
cholesterol from the outer to the inner mitochrondrial membrane (Liu, Rone et al. 
2006). The enzyme, CYP11A1, is located on the matrix side of the inner 
mitochondrial membrane, and catalyzes the conversion of STAR-delivered 
cholesterol to pregnenolone by cleavage of a six carbon unit from 27-carbon 
cholesterol molecule (Simpson and Boyd 1966; Stocco 2000). Subsequently, 
pregnenolone escapes to the cytoplasm where it is converted to progesterone by 
the enzyme HSD3B1 in the microsomes (Pasqualini 2005).  
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In ruminant species, the placental structure comprises numerous 
placentomes in which the trophoblast-derived cotyledon is in apposition to 
endometrial regions known as the maternal caruncles (Wooding 1992). While it is 
essentially an epitheliochorial placenta, there is trophoblastic invasion in the form 
of specialized trophoblast giant cells (TGCs) that inhabit the caruncle (Wooding 
1992). These cells are well known for the synthesis of placenta-associated 
glycoproteins (Hashizume, Ushizawa et al. 2007) and some studies have suggested 
that they produce placental lactogens and progesterone, contributing to fetal and 
placental development (Duello 2005). During the early phase of their formation, 
these TGCs express HSD3B1, but this appears to be extinguished during the latter 
stages of differentiation (Schuler, Greven et al. 2008) 
Previous studies demonstrated that transcripts for STAR, HSD3B1 and 
CYP11A1 are present in both caruncle and cotyledon of the bovine placenta, 
beginning during the first three months of gestation (Takagi, Yamamoto et al. 
2007).  Thus, it would appear that both components of the ruminant placentome 
participate in steroidogenesis.  Given that the absence of information on the 
localization of steroid synthesis, and the enigmatic role of the TGCs in the bovine 
placenta, the aim of this study was to determine the occurrence of candidate 
proteins (STAR, CYP11A1 and HSD3B1), involved in bovine placental 
steroidogenesis and to identify the principal cells implicated in the steroidogenic 
protein expression through the first half of pregnancy.  
 
63 
 
3.3. Materials and Methods 
Sample collection and fixation 
Bos taurus bovine placentas were collected at a local slaughterhouse, with 
four representative samples from each of 50, 70, 90 and 120 days of gestation.  
Gestational age was determined by fetal crown-rump length (CRL). For the period 
Day 50 to Day 70, and the period Day 90 to Day 120 of gestation, estimations were 
calculated based on the Pace et al (2002), and Evans and Sack (1973) 
developmental charts respectively.  From each placenta, three placentomes were 
collected from the mid-region of the uterine horn that contained the fetus, and 
were dissected into caruncle and cotyledon and stored at -80°C until analysis. For 
RNA extraction, the tissues were stabilized with RNA-later (Qiagen, Mississauga, 
ON, Canada) before storage.  Entire placentomes were fixed in Bouin’s solution for 
24 hours. Fixative was then removed and tissues were processed and embedded in 
paraffin and cut at 7 µm for protein localization studies.   
Western blot analysis   
For the preparation of tissue homogenates, small pieces of frozen caruncular 
and cotyledon tissues were powdered individually with pestle and mortar. The 
samples were homogenized in sonication buffer (20 mM Tris, 50 mM EDTA, 0.1 mM 
diethyldithiocarbamate (DEDTC), pH8.0; Invitrogen Life Technologies Corporation, 
Burlington, ON, Canada and Sigma-Aldrich, Oakville, ON, Canada), containing 32 
mM octyl glucoside and protease inhibitor (Complete mini, EDTA-free, Roche, 
Mannheim, Germany).  Mitochondrial and cytosolic proteins were obtained by 
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differential centrifugation (600g for 30 min, then the resultant supernatant was re-
centrifuged at 9000g for 30 min )(Pescador, Soumano et al. 1996).  The protein 
concentration was measured by a Bradford protein assay (Bio-Rad Laboratories, 
California, USA), adjusting the samples to 70 µg of protein.  The proteins were then 
diluted in sample buffer containing 25 mM Tris (pH 6.8), 1 % SDS, 5 % 
mercaptoethanol, 1 mM EDTA, 4% glycerol, and 0.01% bromophenol blue 
(Invitrogen and Sigma-Aldrich).  The samples were boiled for five minutes, and 
then subjected to electrophoresis on a 9% and 12% SDS-PAGE gels.  The low range 
molecular weight marker (Amersham Biosciences, UK Limited) was used as 
reference.  
Samples were electroblotted to nitrocellulose membranes (Bio-Rad, 
Richmond Canada), and the membranes were then blocked with 4% nonfat dry 
milk in Tris Buffered Saline (TBS) buffer containing 0.5% Tween 20 and incubated 
with their respective first antibody overnight.  The first and second antibodies 
were diluted in TBS, at dilutions shown in Table 1. The second antibody 
peroxidase-conjugated Affini Pure Goat anti-rabbit IgG (Jackson Immuno Research 
Laboratories West Grove, PA,  USA), was used at 1:10000 dilution.  Mitochondrial 
and cytosolic proteins from different steroidogenic tissues (mouse adrenal glands 
and bovine corpus luteum) and non-steroidogenic organs (bovine lung) were used 
as positive and negative controls respectively to validate the system (Fig.1). 
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Immunohistochemical staining procedures 
An indirect immunoperoxidase staining streptavidin-biotin method 
(Vectastain Elite ABC Kit PK6101, Vector Laboratories, Burlington ON, Canada) and 
the immunofluorescence techniques were used for the detection of the three 
steroidogenic markers (STAR, CYP11A1and HSD3B1).  Tissue slides were heated in 
10 mM citrate buffer (Fisher Scientific, Ottawa, ON, Canada) for 5 min for antigen 
retrieval.  The sections were blocked with 10% goat serum overnight.  The slides 
were then incubated for 12 h with primary antibodies for the three steroidogenic 
proteins at the concentrations described in Table 1.  For immunoperoxidase 
staining, the slides were incubated with biotinylated secondary antibody (goat anti-
rabbit IgG biotinylated 1:100) and avidin-biotin complex following the 
manufacturer's instructions (Vector Laboratories). Slides were then incubated with 
diaminobenzidine (DAB; Sigma-Aldrich) for 40 sec, and counterstained with 
haematoxylin (Fisher Scientific), for 1 min.  For immunofluorescence, the slides 
were incubated with an appropriate second antibody diluted at 1:1500 (anti-rabbit 
IgG Alexa 488, Invitrogen, California USA), the nuclei were stained with bis 
benzimide trihydrochloride (Hoechst, 33342 Sigma-Aldrich).  We performed 
double fluorescence immunolabeling on placentome slides to identify the 
trophoblast giant cells, using and monoclonal SBU3 antigen antibody, with 
specificity for the placenta associated glycoproteins produced by the sheep 
binucleate trophoblast cells (Lee, Gogolin-Ewens et al. 1985; Lee, Ralph et al. 1990).  
A fluorescein (FITC)-conjugated goat anti-mouse IgG, (Jackson Immuno Research 
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Laboratories) was used for the double immunofluorescence staining.  First and 
second antibodies were prepared in PBS buffer; dilutions for first antibodies are 
shown in Table 1.  Serum from a non-immunized rabbit or mouse was used as a 
negative control.  For the assessment of immunostaining of the three steroidogenic 
proteins, regions within the placentome were defined as shown in Figure 2. 
Messenger RNA isolation and cDNA synthesis 
Total RNA was extracted from 30 mg of caruncular and cotyledon tissues, 
using an RNeasy Mini Kit (Qiagen Mississauga, ON, Canada).  Disruption and 
homogenization of tissue were achieved with mortar and pestle. Proteinase K 
digestion (Invitrogen) was used to remove the proteins which could interfere with 
the RNA isolation. DNase I treatment was applied on the columns to eliminate any 
contaminating DNA (RNase-free DNase Set, Qiagen).  Poly A+ mRNA was isolated 
from total RNA using the Oligotex kit (Qiagen).  The mRNA extracted was quantified 
by measuring the absorbance at 260 nm (A260), and mRNA purity was determined 
by the ratio of 260/280 using a NanoDrop ND-1000 spectrophotometer (Nanodrop 
Technologies, Wilmington, Delaware). For each sample, 1 µg of mRNA was reverse 
transcribed to cDNA using Superscript II Reverse Transcriptase (Invitrogen). 
Quantitative PCR (qPCR) 
The transcript abundance for STAR, CYP11A1, HSD3B1, GAPDH and actin, 
beta (ACTB) was quantified by qPCR using the 7300 Real Time PCR thermal cycler 
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(Applied Biosystem). Sequences of the primer pairs and expected product sizes are 
shown in Table 2. 
Bovine STAR, CYP11A1 and HSD3B1 primers were designed from published 
bovine sequences (Nishimura, Sakumoto et al. 2006; Orisaka, Tajima et al. 2006; 
Murayama, Miyazaki et al. 2008). Glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) and ACTB primers were designed based on bovine gene sequences from 
GenBank, and using the Primer Express software Version 3.0 (PE Applied 
Biosystem). qPCR products from GAPDH and ACTB were subcloned into a pDrive 
cloning vector (Qiagen), and amplified in competent bacteria of XL1-Blue strain.  
Plasmids were isolated with a QIAprep Spin Miniprep kit (Qiagen) and sequenced 
(The McGill University and Génome Québec Innovation Centre, Montreal, Qc) to 
verify that the cDNA amplified fragments corresponded to the target sequences. 
Primer concentrations were optimized according to the manufacturer’s 
recommendations and dissociation curve analysis and agarose gel electrophoresis 
were used to verify the specificity of amplified products. The PCR efficiency (E= 
1.9-2.0) and linearity of each primer were tested by preparing a series of solutions 
of the same stock of cDNA used for the qPCR gene analysis. The geometric mean of 
two reference genes (GAPDH and ACTB) was used as a normalization factor. 
Relative quantification method (ΔΔC t ) was used to determine changes in target 
gene expression levels (Livak and Schmittgen 2001; Pfaffl 2001). Data analysis was 
performed using the Sequence Detection Software version 1.4 (PE Applied 
Biosystems) and the LinRegPCR Software version 11.1 (Heart Failure Research 
68 
 
Center Academic Medical Centre Amsterdam, the Netherlands). Reactions for qPCR 
were conducted in sealed 96-well (SARSTEDT INC, Montreal, QC Canada) in 
triplicate. The total volume of the qPCR reaction was 20 µL, comprising 6 µL cDNA 
template (diluted 1 in 15 in distilled water), 2 µL each forward and reverse primers 
and 10 µl Power SYBR green PCR master mix (Applied Biosystems,). Cycling 
conditions were 2 min at 50°C and 10 min at 95°C, followed by 40 cycles of 15 sec 
at 95°C and 60 sec at 60°C.   
Statistical analyses 
The optical density of the protein bands was quantified by ImageJ 1.31v 
software (Wayne Rasband, National Institutes of Health, USA). For STAR, CYP11A1 
and HSD3B1 protein expression, optical density data were log-transformed to 
reduce heterogeneity of variance, and obtain normality of distribution (Shapiro-
Wilk, normality test). For qPCR, STAR and CYP11A1 relative gene expression had a 
normal distribution. In addition, HSD3B1 expression was log-transformed to 
achieve normality.  
Differences in mRNA and protein relative expression between the groups 
were statistically evaluated by a two-way analysis of variance, followed by all 
pairwise multiple comparison procedures (Holm-Sidak method).  All statistical 
analysis was conducted with SigmaPlot (version 11.2, Systat software, 
Incorporation). Data are expressed as the mean + standard error (SE), and values of 
P < 0.05 were considered significant.  
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3.4. Results  
Expression of STAR in caruncular and cotyledonary tissues 
  By Western blot, the polyclonal anti-STAR antiserum identified a single 
band of 30 kDa in caruncle and cotyledon at all time points studied through 
pregnancy (Fig. 3 panel A).  In caruncles, there was significant reduction in STAR 
protein around day 70 of gestation compared to other time points (Fig. 3 panel A).  
Moreover, significant differences were found in cotyledonary tissues between days 
50 and 90, compared with days 70 and 120 (Fig. 3 panel B).  Significant differences 
in STAR protein abundance were found between caruncles and cotyledons at 50, 70 
and 90 days of gestation, showing a complementary pattern of expression between 
maternal and fetal components of the placenta (Fig. 3 panel B) such that when 
cotyledonary expression of STAR was diminished, the abundance of STAR in the 
caruncle increased and vice versa, suggesting a regulatory mechanism to maintain 
an optimal level of steroid output by the placenta.   
No significant differences were found in the relative abundance of STAR 
transcripts in or between caruncles and cotyledons during the first third of 
gestation (Fig. 4A). However the mRNA expression between caruncles and 
cotyledons at all studied periods reflected the same pattern of protein expression 
between the aforementioned tissues.   
Immunohistochemistry revealed that, at all periods investigated, bovine 
STAR protein staining was mostly restricted to the materno-fetal interdigitations 
with emphasis in the maternal septum. Occasionally, moderate staining was 
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observed in the chorionic plate and in the trophoblast of the chorionic villous tree 
(Fig.5A-B).  Cytoplasmic STAR protein expression was clearly detected in the UTCs, 
stromal cells from chorionic villus tree, CECs and CSCs (Fig. 5 D and G).  Expression 
was never detected in trophoblast giant cells (Fig.5 G-I), suggesting that, at least in 
the first third of pregnancy, the TGCs cells do not participate in the steroidogenic 
process.  
Expression of CYP11A1 in caruncular and cotyledonary tissues 
A 50 kDa band corresponding to the CYP11A1 protein was detected by WB 
in caruncular and cotyledonary tissues in samples taken during the first half of 
gestation (Fig. 3 panel A).  The abundance of CYP11A1 protein in caruncles was 
significantly increased at day 90 of pregnancy, compared to the remainder of the 
times sampled (Fig. 3 panel A and B).  In cotyledons, significant differences 
between 50 and 120 days of gestation were found, showing a decrease in protein 
abundance as the gestation progress (Fig. 3 panel B).  Greatest differences in 
CYP11A1 protein abundance were found between cotyledon and caruncle at day 50 
(Fig.3 panel B).  The CYP11A1 mRNA expression levels showed the same pattern of 
protein expression at day 70 and 90 of gestation. However no significant mRNA 
differences were found at any investigated period (Fig. 4B).   
 CYP11A1 was localized principally in CP, fetal trophoblast and in the 
interdigitation area: CV and MS (Fig. 6A and B). As with STAR protein, the principal 
cells that stained positive for CYP11A1 at all periods were the UTCs, stromal cells 
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from chorionic villus tree, and CSCs (Fig. 5D and G). No CYP11A1 was detected in 
TGCs at any time studied (Fig. 6 G-I).  
Expression of HSD3B1 in caruncular and cotyledonary tissues 
By western blot, a band migrating at approximately 42 kDa protein, 
corresponding to the HSD3B1 protein was identified only in caruncular tissues (Fig. 
3 panel A).  Statistical analysis revealed HSD3B1 protein abundance in this tissue 
was significantly more important in the maternal component of the placenta at day 
50, compared with day 120 of pregnancy (Fig. 3 panel B).  
In contrast to the protein expression pattern, the HSD3B1 mRNA abundance 
in cotyledons tended to be higher than in caruncles. However, significant 
differences between both tissues were found only at day 70 and 120 of gestation 
(P<.05). (Fig.4C). HSD3B1 mRNA abundance in cotyledonary tissue at 70 days of 
gestation was significantly higher than the rest of the periods in the same tissue 
(P<.05).  On the other hand, no differences between periods in caruncular tissue 
were found (Fig. 4C).  Differences found between protein expression patterns and 
mRNA expression could be related to posttranscriptional HSD3B1 regulation.  
By immunohistochemistry, the HSD3B1 protein staining was strongest on 
the maternal side, where it was found in the feto-maternal interdigitations, 
predominantly in the maternal septum and the caruncular epithelium (Fig. 7 A and 
B). On the cotyledonary side, expression was localized in UTCs, and the TGCs 
exhibited no evidence of HSD3B1 expression (Fig. 7 D-I).  
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3.5. Discussion 
Studies in vitro and in vivo have demonstrated that the bovine placenta 
contains the enzymes and proteins to produce steroid hormones in late gestation 
and at parturition (Evans and Wagner 1981; Gross and Williams 1988; Pescador, 
Soumano et al. 1996; Pilon, Daneau et al. 1997; Takagi, Yamamoto et al. 2007). 
Moreover the fact that bovine pregnancy can survive luteolysis and ovariectomy 
during the last 70 days of gestation (Day 1977; Chew, Erb et al. 1979), indicates 
that the placenta can provide the steroid support required for the maintenance of 
gestation. A functional role for local steroid production in the bovine placenta has 
been demonstrated by the presence of both estrogen and progesterone receptors in 
the maternal caruncle (Hoffmann and Schuler 2002). 
 This study provides new information on the cellular origin of bovine 
placental steroids. It appears that the sites of synthesis of steroids differ from other 
species in which placental steroidogenesis occurs.  In rodents, steroidogenic mRNA 
markers, including STAR, CYP11A1 and HSD3B1 are expressed in the trophoblast 
giant cells, while HSD3B1 appears transiently in the maternal decidual 
(differentiated endometrial stromal) cells (Arensburg, Payne et al. 1999).  In 
primates, steroid synthesis in the placenta appears restricted to the 
syncytiotrophoblast (Albrecht and Pepe 1999). Results of the present study 
indicated that in cattle, both the maternal and fetal tissues contribute to hormone 
synthesis through early gestation.  Our results confirm the results from a previous 
study where transcripts for STAR, HSD3B1 and CYP11A1 are present in both 
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caruncular and cotyledonary tissues of the bovine placenta through gestation 
(Takagi, Yamamoto et al. 2007) 
Protein and mRNA of STAR and CYP11A1 were found in caruncles and 
cotyledons from 50 to 120 days of gestation. HSD3B1 protein expression was only 
found in caruncles; in contrast the transcript was found in both caruncular and 
cotyledonary tissues.  In the present study the mRNA expression of HSD3B1 in the 
caruncle was observed to be significantly reduced compared to cotyledonary 
tissues. Similarly Takagi et al (Takagi, Yamamoto et al. 2007), observed similar 
expression patterns for HSD3B1 transcript in bovine placenta during gestation and 
postpartum.  
The discordance between the mRNA and protein expressions of this enzyme 
implies the existence of posttranscriptional regulation on HSD3B1 gene expression 
in cotyledonary tissue.  Such posttranscriptional regulation could indicate a 
potential regulation of HSD3B1 by RNA binding proteins from the transcription to 
the translation of this enzyme.   
Similar observations were reported for CYP11A1, CYP17A and HSD3B1 genes 
in neonatal pig testes, where mRNA levels of these enzymes was significant 
increased, but protein levels were lower (Choi, Kim et al. 2009). However the 
underlying mechanism of this modulation is unknown. 
In agreement with earlier reports (Conley, Head et al. 1992; Izhar, 
Pasmanik et al. 1992; Takagi, Yamamoto et al. 2007), in the present study, the 
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CYP11A1 protein and mRNA expression remained relatively constant through 
gestation. In situ analysis concurs in demonstrating CYP11A1 and HSD3B1 
transcripts in bovine trophoblast cells (Schuler, Greven et al. 2008).   
Protein analysis by immunoblotting and immunohistochemistry confirmed 
the presence of all three steroidogenic proteins on the maternal side.  The signal 
for HSD3B1 on the fetal side is apparently low in tissue sections and below the 
level of detection by immunoblotting procedure.  The paucity of this important 
steroidogenic enzyme on the fetal side may indicate that progesterone and other 
downstream steroids are synthesized primarily by the maternal caruncle during 
early gestation.  This notwithstanding, Conley and Ford (1987) demonstrated that, 
in vitro, isolated cotyledonary and caruncular components from bovine 
placentomes, taken at day 200 of gestation, both produce progesterone from 
pregnenolone substrate. Furthermore this conversion was abrogated by a 
HSD3B1 inhibitor.  Whether this is a phenomenon of later pregnancy awaits 
further investigation.  
In the ruminant placenta, 20 or more percent of the trophoblast cells are in 
the binucleate population (Wooding, Morgan et al. 1996).  These cells are derived 
from the mononucleate trophoblast population by a process that includes 
acytokinetic mitosis (Wimsatt 1951) and endoreduplication such that they can 
contain a complement of DNA up to 32n (Klisch, Pfarrer et al. 1999).   It has been 
reported that these cells migrate throughout gestation into the maternal 
endometrial epithelium, where some fuse, resulting in trinucleate feto-maternal 
75 
 
cells (Klisch, Pfarrer et al. 1999). More is known about their structure than their 
function. They synthesize and secrete the pregnancy associated glycoproteins 
(PAGs), and placental lactogen (Beckers, Zarrouk et al. 1998).  The results of the 
present study indicate that, in the samples tested during the first third of gestation, 
the binucleate cells do not express any of the three proteins required for the 
initiation of steroidogenesis and for progesterone synthesis. In this context, by 
immune electron microscopy, Ben-David and Shemesh (1990) localized the 
CYP11A1 in the mitochondria of caruncular epithelial cells and the uninucleate 
trophoblast cells, but not in trophoblast giant cells during bovine midgestation.  
Moreover, cytochrome P450, family 17, subfamily A, polypeptide 1 (CYP17A1) has 
been detected exclusively in uninucleate trophoblast cells, where it was 
immediately down-regulated when these cells entered the trophoblast giant cell 
differentiation pathway between days 90-150 (Schuler, Ozalp et al. 2006).  In situ 
analysis (Schuler, Greven et al. 2008) demonstrated the presence of HSD3B1 
transcripts in differentiating but not in mature bovine placental binucleate cells.  It 
is believed that binucleate cells continue to differentiate from uninuclear 
trophoblast cells through gestation (Klisch, Hecht et al. 1999; Klisch, Pfarrer et al. 
1999).  If the HSD3B1 protein were present, it should have been visible in 
binucleate cells in our studies.  As noted above, while HSD3B1 mRNA was present 
in cotyledonary tissue, the immunohistochemical signal was weak; the abundance 
of this enzyme was below the level of detection by immunoblotting in these cells.  
Although we have not exhaustively sampled through the period in question, the 
results from the present investigation suggest that the binuclear cells of the 
76 
 
trophoblast do not participate directly in steroid synthesis during the first third of 
gestation.  
It remains possible that the trophoblast giant cells function in conversion 
and metabolism of locally produced steroids.  Indeed, sulfotransferase family 1E, 
estrogen-preferring, member 1 (SULT1E1)  activity was found  in cotyledons and in 
the trophoblast giant cells (Nash, Glenn et al. 1988; Hoffmann, Falter et al. 2001; 
Ushizawa, Takahashi et al. 2007), suggesting a two-compartment organisation, 
where the steroids produced in caruncular tissue are transformed in steroid 
sulphates by cotyledonary tissue.  The sulphate conjugation in cotyledons may 
inactivate and/or catabolize steroids and contribute to protection of the fetus from 
effects of the free steroids produced by caruncles.  Moreover, the caruncle exhibits 
pronounced steroid sulphatase activity, indicating that the caruncle is capable of 
processing steroids from estrogen sulphates, produced by cotyledonary tissue 
(Hoffmann, Falter et al. 2001; Ushizawa, Takahashi et al. 2007).  Confirmation of 
this hypothesis awaits further experimentation.  
The role of placental steroid hormones in cattle is not well understood, 
presumably due to the lack of a method for the selective interruption of placental 
steroid production in vivo.  Apart from acting as classical endocrine hormones, the 
placental progestins and estrogens may also function as autocrine or paracrine 
regulators, as has been demonstrated in testis and ovary (Zirkin 1998; Schuler, 
Wirth et al. 1999; Slomczynska and Wozniak 2001). Not surprisingly, the receptor 
for progesterone is present in the caruncular stroma and epithelium, and it has 
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been suggested that this steroid, of ovarian or placental provenance regulates 
placental development (Hoffmann and Schuler 2002).  Given the role of 
progesterone in gestation in other species, it is presumed that local synthesis 
serves to inhibit myometrial activity to ensure fetal development. 
In conclusion, we have demonstrated the capability of the early bovine placenta to 
initiate steroidogenesis.  It is of interest that both the maternal and fetal 
components participate in the process, perhaps in a complementary fashion.  The 
caruncular tissue expresses all three steroidogenic proteins (STAR, CYP11A1 and 
HSD3B1), suggesting that the maternal compartment exhibits greater steroidogenic 
capacity than cotyledon during the first third of pregnancy. In contrast to other 
investigations, our studies suggest that the trophoblast giant cells are not a source 
of placental steroids, at least during the first third of gestation.  
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3.7. TABLES AND FIGURES 
Table1. First antibodies and concentrations employed for western blotting (WB) 
and immunohistochemical staining procedures (IMH) in bovine placenta 
 
Antibody Specificity Company Dilution 
WB 
Dilution 
IMH 
ACTB  Rabbit polyclonal antibody against a 
synthetic peptide (KLC-coupled) 
corresponding to amino-terminal 
residues of human β-Actin  
Santa Cruz Biotechnology, 
Inc.  
California USA  
1: 1 000  
 CYP11A1  Rabbit anti-rat cytochrome P450 scc 
polyclonal antibody  
Chemicon, International, 
Ontario Canada.  
1:1 000  1:200
HSD3B1  Rabbit anti-rat 3beta-HSD polyclonal 
antibody  
Santa Cruz Biotechnology, 
Inc. California USA  
1:1 500  1:200
SBU-3  Mouse anti-sheep carbohydrate 
moiety expressed in trophoblast 
giant cells  
Department of Veterinary 
Preclinical Sciences. 
University of Melbourne. 
Australia  
 1:50
STAR  Rabbit polyclonal antibody to amino 
acids 88-98 of mouse StAR protein  
Provided by Dr. 
D.M.Stocco, Texas Tech 
University  
1:1 000  1:100
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Table 2. Primer pairs used for mRNA detection in bovine placenta  
 
Genes  qPCR primers sequence (5'–3')  Fragment 
size (bp)  
References/accession 
no.  
Primer 
concentration  
ACTB  FWD 
GGATGAGGCTCAGAGCAAGAGA  
REV TCGTCCCAGTTGGTGACGAT  
58 NM_173979  FWD 3 µM 
REV  3 µM 
CYP11A1 FWD CTGCAAATGGTCCCACTTCT 
REV  CACCTGGTTGGGTCAAACTT 
209 Murayama et al. 
(2008)/ NM_176644   
FWD 9 µM 
REV  1.5 µM 
GAPDH FWD 
GGCGTGAACCACGAGAAGTATAA  
REV CCCTCCACGATGCCAAAGT  
100 NM_001034034 FWD 9 µM 
REV  3 µM 
HSD3B1  FWD GCCCAACTCCTACAGGGAGAT 
REV  TTCAGAGCCCACCCATTAGCT 
114 Orisaka et al. (2006)/ 
NM_174343.2  
FWD 1.5 µM 
REV  3 µM 
STAR  FWD CCCATGGAGAGGCTTTATGA 
REV TGATGACCGTGTCTTTTCCA 
115 Nishimura et al. (2006) 
/ NM_174189.2  
FWD 9 µM 
REV  3 µM 
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Figure 1. Positive and negative controls to validate the western blot system in 
bovine placenta. Western blot control of mitochondrial and cytosolic protein 
(35µg) prepared from mouse adrenal gland (positive control), bovine corpus 
luteum (positive control), and bovine lung (negative control).  
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Figure 2. Diagram representing the bovine placentome. Triangle shows the feto-
maternal interface. The white frame (A) is enlarged and depicts an interdigitation. 
(B) Maternal septum, (C) Chorionic villus, (1) Trophoblast giant cells, (2) 
Caruncular epithelial cells, (3) Caruncular stromal cells, (4) Uninucleate 
trophoblast cells.  
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Figure 3. Characterization of steroidogenic proteins by western blot (WB) analysis 
(70 µg per lane) prepared from bovine placental tissues. (Panel A) STAR, CYP11A1 
and HSD3B1  protein in caruncles  and cotyledons at different ages of gestation. 
(Panel B) Means ± SEM of STAR, CYP11A1 and HSD3B1 protein between caruncles 
and cotyledons at different periods of gestation. ACTB served as loading and 
constitutive control. Gray bars represent caruncular tissue, and white bars 
represent cotyledonary tissue. Means with different superscripts are significantly 
different (P<0.05) (n=4). The WB images correspond to one of the four 
representative replicates. 
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Figure 4. Characterization of mRNA in bovine placental tissues. (A-C). Expression 
of STAR, CYP11A1 and HSD3B1 mRNA in caruncles and cotyledons at different ages 
of gestation. Results are shown as relative mRNA expression for each gene 
normalized to the reference gene values, and they are expressed as the mean ±SEM. 
Gray bars represent caruncular tissue, and white bars represent cotyledonary 
tissue. Means with different superscripts are significantly different (P<0.05) (n=4).. 
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Figure 5. Characterization of STAR expression in bovine placentomes. (Panel A-B) 
Characteristic staining pattern of STAR protein in a 70 day pregnant cow by 
immunoperoxidase technique (IP). (A) Considerable staining (brown zones) is 
localized at chorionic plate (CP) and in the interdigitation area: chorionic villi (CV) 
and maternal septum (MS). (B) Typical cellular staining pattern in the same cow, 
shows STAR expression in the feto-maternal interdigitations. The staining is 
restricted principally to the caruncular epithelial cells (white arrow), caruncular 
stromal cells (white arrowhead) and the uninucleated trophoblast cells (black 
arrow), compared to the negative control in panel C. Panel D-I represents 
immunofluorescence in bovine placentomes at day 90 of gestation. (Panel D) In 
maternal septum, alexa marker (red) indicates STAR cytoplasmic expression on the 
caruncular epithelial cells (CECs). (F) CECs were negative to SBU-3 by FITC 
staining. (G) Uninucleate trophoblast cells (UTCs) stained positive for STAR (red) in 
chorionic villi. In panel G and I, trophoblast giant cells (TGCs) stained negative for 
STAR, and positive for SBU-3 (green) respectively. (E and H) Nuclei counterstained 
with Hoechst (blue). Bars represent .1 mm in panel A, and .05 mm in panels B to I.  
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Figure 6. Characterization of CYP11A1 expression in bovine placentomes. (A-C) 
Characteristic staining pattern in a 50 day pregnant cow by immunoperoxidase 
technique (IP); significant staining is localized at chorionic plate (CP) and in the 
interdigitation area: chorionic villi (CV) and maternal septum (MS). (A) Typical 
cellular staining pattern in the feto-maternal interdigitations, which is restricted 
principally to the caruncular epithelial cells (CECs) (black arrow). Panel C 
represents the IP negative control. (Panel A-B) Trophoblast giant cells (TGCs) (star) 
were negative for CYP11A1 by immunoperoxidase techinque. Panel D-I represents 
immunofluorescence in bovine placentomes at day 90 of gestation. (Panel D and G) 
In maternal septum and in chorionic villi, alexa marker (red) shows CYP11A1 
cytoplasmic expression on the CECs and on the uninucleate trophoblast cells 
(UTCs). On the other hand, panel D and G show that TGCs do not stain positive for 
CYP11A1. Conversely, in panel I, TGCs stained positively for SBU-3 (green). (E) 
Nuclei were counterstained with Hoechst (blue). Bars, .05 mm.  
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Figure 7. Characterization of HSD3B1 expression in bovine placentomes. (A-B) 
Characteristic staining pattern in a 50 day pregnant cow by immunoperoxidase 
technique (IP). Significant staining is restricted to chorionic plate (CP) and to the 
interdigitation area: chorionic villi (CV) and maternal septum (MS). Typical cellular 
HSD3B1 staining pattern in the materno-fetal interdigitations is restricted principally to 
caruncular epithelial cells (CECs) (black arrow), caruncular stromal cells (CSCs) (black 
arrowhead), and the uninucleate trophoblast cells (UTCs) (white arrow). (Panel A-B) 
Trophoblast giant cells (TGCs) were negative for HSD3B1 (black star). Panel C 
represents the negative control by IP. (D -I) Immunofluorescence in bovine 
placentomes at day 90 of gestation. (Panel D and G) In the interdigitations, alexa 
marker (red) shows HSD3B1 cytoplasmic expression only on the UTCs. In Panel H and I, 
TGCs stained postive for SBU-3 (green) but negative for HSD3B1.Panel E shows nuclei 
counterstained with Hoechst (blue). 
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4.1. Abstract 
Pregnancies derived from a somatic cell nuclear transfer (SCNT) cloning have been 
associated with high rate of fetal loss, especially during the first trimester. The 
SCNT-derived placentae at term show gross morphological abnormalities, such as 
large and fused placentomes. The bovine placenta synthesizes steroids that are 
expected to regulate placental function and fetal development. The objective of this 
study was to compare expression of a series of genes and proteins coding for 
steroidogenic enzymes between SCNT and AI placenta, and SCNT and non-clone 
gestations (NG) respectively. Additionally we investigated by fluorescent 
immunohistochemistry and confocal microscopy the localization of scavenger 
receptor class B member I (SCARB1), cytochrome P450, family 11, subfamily A, 
polypeptide 1 (CYP11A1) and cytochrome P450, subfamily XVII (CYP17A1) in 
normal pregnancies.  Differential expression of SCARB1, steroidogenic acute 
regulatory protein (STAR), hydroxy-delta-5-steroid dehydrogenase, 3 beta- and 
steroid delta-isomerase 1 (HSD3B1), CYP17A1, CYP11A1, steroid sulfatase (STS) and 
sulfotransferase family 1E, estrogen-preferring, member 1 (SULT1E1) between AI 
and SCNT cotyledons was measured by quantitative real time PCR. Protein 
expression of STAR, CYP11A1 and HSD3B1 was analyzed by western blotting in 
SCNT and NG. There was a reduction in the abundance of transcripts for STAR, 
CYP11A1, HSD3B1, CYP17A1 and SULT1E1 (P< 0.01) in placentas from SCNT 
compared to AI gestations.  Protein localization of SCARB1, CYP11A1 and CYP17A1 
was restricted to uninucleate trophoblastic cells, indicating that these are the main 
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cell type responsible for steroid synthesis in day 40 placentae. The reduced 
abundance of STAR transcripts in placenta derived from cloned animals suggests 
deficient cellular transfer of cholesterol across the mitochondrial membrane. 
Altered levels of the CYP11A1, HSD3B1 and CYP17A1 in cloned gestations are 
expected to lead to a reduction in steroids synthesis by the placenta. A reduced 
capacity to synthesize steroids may contribute to the abnormal placental and fetal 
development associated in SCNT pregnancies.  
 
Key words: SCNT gestations, bovine placentae, placental steroids. 
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4.2. Introduction 
Somatic cell nuclear transfer technology has many potential applications in 
the agricultural and biomedical fields. However, bovine pregnancies derived from 
SCNT have been associated with high rate of fetal losses, which, in most cases 
happen during the first trimester of gestation [1]. Some of the alterations reported 
in these pregnancies are related with defective allantoic vascularisation, edematous 
chorioallantoic membranes, morphological anomalies of placentomes, dystocia and 
perinatal loss and anomalies [1-4]. Moreover, the poor survivability of cloned 
fetuses during the first third of pregnancy is associated with alterations in the 
chorioallantoic development [5]. Proper progress of placental development is 
critical for normal development of the fetus. Alterations in some factors that 
promote placental and vascular development have been pointed as possible causes 
of SCNT failures [6]. In this regard, alterations in the expression of cytokines such 
as:  insulin-like growth factor 1 (IGF1), insulin-like growth factor binding protein 1 
(IGFBP1) and transforming growth factor, beta-1  (TGFB1) were found in placenta 
from bovine SCNT pregnancies [7, 8].  It is well known that the placenta produces 
steroid hormones that play important functions in the establishment and 
maintenance of pregnancy in many species. In normal gestations, the presence of 
steroidogenic markers have been found in the bovine placenta [9-14].   
Recently, we found the principal steroidogenic markers (STAR, CYP11A1 
and HSD3B1) in bovine placenta during the first third of pregnancy (Verduzco et al, 
unpublished). We have also identified the principal regions and cells implicated in 
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the steroidogenic process in the bovine placenta. However, expression of other 
steroidogenic factors, such as cholesterol transporters (HDL or LDL) and other 
steroidogenic enzymes that could contribute to the synthesis of steroids in the 
bovine placentae, have not been investigated. Moreover, little is known about sub-
optimal steroid synthesis in SCNT bovine pregnancies.  
Given the importance of steroid hormones for placental and fetal 
development, the aim of this study was to characterize the patterns of expression of 
mRNA and protein of some of the main steroidogenic factors (SCARB1, STAR, 
CYP11A1, HSD3B1, CYP17A1, STS and SULT1E1), which could be dysregulated in 
SCNT placentae, contributing to the placental and fetal developmental 
abnormalities associated with this technique. We have further evaluated the 
protein expression of key steroidogenic factors (SCARB1, CYP11A1 and CYP17A1) 
in early non-clone pregnancies. Additionally, we analyzed the expression and 
localization of SCARB1, CYP11A1, and CYP17A1 in bovine placenta from AI 
gestations.  
4.3. Results 
Messenger RNA abundance of STAR, CYP11A1, HSD3B1, CYP17A1 and 
SULT1E1 were significantly lower in cotelydons from SCNT pregnancies compared 
to those from AI placenta (Figure 1).  No significant differences in transcript 
abundance of SCARB1 and STS were found.  In western blots, the STAR antibody 
recognised a band with an approximate molecular weight of 30 kDa in NG and 
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SCNT groups; which corresponds to the mature form of STAR protein [23] (Figure 
2). However the intensity of the bands was weak in both experimental groups and 
only two of four samples in the SCNT group showed the presence of the protein. 
There was no significant difference between SCNT and NG cows.  Anti-CYP11A1 
antibody recognized a band of approximately 50 kDa, corresponding to the size of 
this protein in cattle.  CYP11A1 protein abundance did not differ between SCNT and 
NG cows (Figure 2). As we observed in a previous study (Verduzco et al., 
unpublished), HSD3B1 protein was not detected in the samples from NG. 
Surprisingly, the presence of a 42 kDa band, which corresponds to the HSD3B1 
bovine protein, was found in two cows from SCNT group (Figure 2). However, only 
one of the two samples showed band intensity; and no significant differences were 
found between the two experimental groups.  
Immunofluorescence revealed that, in AI gestations, SCARB1 was mostly 
restricted to uninucleate trophoblast cells, and in vascular smooth muscle form 
some blood vessels. In contrast no expression or reduced expression was found in 
trophoblast giant cells (Figure 3). Anti-CYP17A1 antibody yielded scarce 
expression in uninucleate trophoblast cells; once again in trophoblast giant cells a 
weak to absent staining was observed (Figure 4). Specific expression of CYP11A1 
was observed in fetal stromal cells, uninucleate trophoblast cells and stromal 
uterine cells. Trophoblast giant cells showed a weak or absent staining (Figure 5).   
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4.4. Discussion  
In bovine SCNT pregnancies, abnormal placentation is a major factor of 
pregnancy failure in first trimester [5, 24-26]. In domestic animals, the placenta 
produces a variety of steroid and protein hormones that support conceptus growth 
and development. Bovine placenta produces steroid hormones; and receptors for 
these hormones have been identified in this tissue [27, 28]. A putative role of 
placental steroids as local regulators of placental growth, differentiation and 
function has been suggested [28-31]. Based on the aforementioned, the present 
study investigated possible alterations in the expression of the principal 
steroidogenic factors in placentas from cloned embryos. The placenta is a vital 
organ for cholesterol transfer from the mother to the fetus.  
Low density lipoproteins (LDL) and high density lipoproteins (HDL) are 
taken up from maternal plasma by LDL and SCARB1 receptors respectively [32].  In 
the present study, no alterations were found in transcript levels of SCARBI in SCNT 
pregnancies compared to control gestations. This suggests that the selective uptake 
of HDL cholesteryl ester mechanism is not affected in SCNT gestations.  Conversely, 
we clearly demonstrated that some of the principal steroidogenic genes (STAR, 
CYP11A1, HSD3B1, CYP17A1 and SULT1E1) in bovine placenta were altered and 
lower in cloned pregnancies where compared to conventional gestations. It is well 
known that transcripts of the abovementioned genes, encode proteins which are 
pivotal in the progesterone, mineralocorticoids, glucocorticoids, androgens, 
estrogens and oestrone sulphates biosynthesis. The aforementioned hormones, 
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especially progesterone and estrogens, exert a local, paracrine and autocrine effects 
in placental and foetal tissues [28, 33-35]. To our knowledge, this is the first study 
to document clearly, atypical expression of some of the principal steroidogenic 
genes in bovine placenta from early SCNT pregnancies. Previous studies, reported 
deregulation of imprinted and non-imprinted genes, essential in the regulation of 
placentogenesis, fetogenesis, mammogenesis, steroidogenesis, and immune system 
activity in the SCNT bovine gestations [6, 24, 36-38]. Moreover, some authors 
suggested that alterations in vascular development of placenta from clones could 
also be due to modifications in the expression of placental factors [39, 40]. 
Therefore, it appears that variation in the expression of steroidogenic genes might 
lead to a wide range of effects on placental and fetal growth that could compromise 
the proper progression of pregnancy. 
In contrast with our results, some authors reported upregulation of SULT1E1 and 
CYP11A1 mRNA expression in preterm and term placentas from SCNT gestations 
[20, 41].    The discrepancy between the results in advanced pregnancies and our 
results may be related to the stage of the gestation. The principal function of the 
SULT1E1 is the sulphoconjugation of estrogens, inhibiting the estrogen activity by 
conjugating a sulfonate group to estrogens and preventing the estrogen receptor 
binding [42]. Conversely, the STS enzyme is responsible for the hydrolysis of 
estrone sulfate and dehydropiandrosterone sulfate to estrone and 
dehydroepiandrosterone, respectively, both of which can be converted to free 
steroids [12, 43]. The cooperation of the two aforementioned enzymes controls the 
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availability of free, active estrogens.  In spite of the lack of function and production 
of estrone sulphates by SULT1E1 in early bovine placenta; we speculate that 
perturbations of SULT1E1 in SCNT transcripts could firstly induce an imbalance in 
the regulatory STS-SULT1E1 system in bovine placenta, affecting the synthesis of 
estrogen sulphates. However, in the present experiment, no difference in transcript 
of STS gene was found in SCNT pregnancies. Consistent with this view, Hirayama et 
al [20], found no difference between SCNT and normal placentae at parturition.  
Alternatively, differences found between early and late gestations, may be 
associated with individual compensatory mechanisms that could be triggered 
during gestation in order to overcome disrupted expression of important genes in 
the placenta, as previously reported [39]. If this is the case, we cannot exclude the 
possibility that low mRNA SULT1E1 in SCNT is compensation to the perturbations 
in the synthesis of steroid hormones. Reduction of the oestrone sulphates synthesis 
would regulate the availability of free steroids.  
In contrast to findings in qPCR, in the present study the western blot results 
did not show significant differences in STAR, CYP11A1 and HSD3B1 abundance in 
SCNT gestations versus NG. These results suggest that differences in steroidogenic 
genes transcription in SCNT gestations did not result in significant protein 
differences in cotyledonary tissue. In further contrast with our results, previous 
investigations in late SCNT gestations found higher plasma concentrations of 
estrone sulphate and progesterone (P4) in cows that aborted or that had prolonged 
gestations respectively [44]. In this context, Hoffert-Goeres et al [40], studying 
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genes associated with impaired placental angiogenesis in NT pregnancies, found 
also discrepant results between transcripts and protein expression.  Based on this 
observation, we propose that the resulting aberrant expression of steroidogenic 
genes found in this study, might have an impact in the expression of steroidogenic 
proteins and steroids synthesis in a long term at other developmental stage with 
effects measurable only at a later time in gestation.  
Intriguingly, and contrary with our previous finding [45], where HSD3B1 
protein was absent in cotyledonary tissue; in this experiment only one sample from 
SCNT gestations  expressed this enzyme.  This fact suggests the possibility that not 
all cloned embryos have the same disturbances in genome reprogramming after 
cell nuclear transfer in oocytes. Other authors [46], have noted the importance of 
individual analyses of cloned animals, since the variation in mean expression levels 
could mask gene expression abnormalities present in individual clones. However, 
whether aberrant gene expression is part of the origin of placental dysfunction or 
just a consequence of abnormal placental development is yet to be established.  
We evaluated the expression of SCARB1, CYP17A1 and CYP11A1 in AI 
gestations by immunohistochemistry. Protein localization of SCARB1, CYP11A1 and 
CYP17A1 was restricted to uninucleate trophoblastic cells indicating that these are 
the main cell type responsible for steroid synthesis in day 40 placentae.  These 
results agree with some reports [13, 45, 47] in ovine and bovine placenta, which 
demonstrated that CYP17A1 and CYP11A1 were exclusively found in the columnar 
trophoblast cells.  A similar pattern of expression was observed for the SCARB1 
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receptor, where only the uninucleated trophoblast cells expressed the receptor. 
Human placenta expresses SCARB1 [48]. To our knowledge, this is the first study 
that localized the expression of SCARB1 in bovine placental tissue. Together this 
suggests that the principal cells implicated in the transport of cholesterol and the 
steroid production in cotyledonary tissues are the uninucleate trophoblast cells.  
In conclusion, our results suggest that in clone pregnancies, the expression 
of important steroidogenic markers by placenta are disrupted, and this 
phenomenon could be traduced in an insufficient biosynthesis of steroid hormones, 
and also in inadequate placental and fetal growth. Considering the complexity in 
regulation of steroids biosynthesis in bovine placenta, further studies are necessary 
for understanding the molecular mechanisms implicated in   SCNT failures, and 
their compensatory effects.  
4.5. Materials and methods  
Animals and sample collection 
Investigations were conducted in accordance with the Canadian Council of 
Animal Care recommendations and approved by the Université de Montréal 
Committee on Animal Care and Experimentation. The method to generate somatic 
cell nuclear transfer embryos have been described previously [15] using a single 
nuclear donor cell line. Control pregnancies were derived by artificial insemination 
(AI) of Holstein heifers with semen from a single Holstein bull.  SCNT and AI cows 
were slaughtered on day 40 of gestation (AI, N=8; SCNT, N=8).  A second set of 
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samples from SCNT (N=4) at day 40 of gestation; and non-cloned gestations (N=4) 
between days 40 – 50 of gestation, were used for the protein analysis. The non-
cloned gestations were collected at a local slaughterhouse, and gestational age of 
placenta was determined by fetal crown-rump length (CRL) as described 
previously [16]. Cotyledonary tissues from the mid-region of the uterine horn that 
contained the fetus were collected for each gestation.  Cotyledon samples from 
SCNT and AI were both stabilized with RNA-later (Qiagen, Mississauga, ON, 
Canada) and stored at -80°C until RNA extraction. For protein extraction, 
cotyledonary tissues from SCNT (N=4) and NG (N=4) were snap-frozen in liquid 
nitrogen and stored at -80°C prior to protein extraction.  Adjacent sections of 
cotyledonary tissues (n=4) were collected from AI cows fixed in 4% buffered 
paraformaldehyde (PAF) solution embedded in paraffin and processed for 
imunohistochemistry by routine procedures. 
The goal in the first instance was to determine the mRNA expression levels 
of SCARB1, STAR, HSD3B1, CYP11A1, CYP17A1, STS, and SULT1E1 genes in 
cotyledonary tissues of SCNT and AI pregnancies. Furthermore, we analyzed 
protein levels of STAR, HSD3B1 and CYP11A1 proteins in NG and SCNT gestations.  
Subsequently, fluorescent immunohistochemistry was used to investigate the 
localization of SCARB1, CYP11A1 and CYP17A1, factors that play an important role 
in the importation of cholesterol, and steroid biosynthesis, and which have not 
been thoroughly investigated in bovine placenta.   
RNA extraction and cDNA synthesis 
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Total RNA was isolated from 30 mg of cotyledonary tissues from SCNT and 
AI pregnancies, using an RNeasy Mini Kit (Qiagen), according to the manufacturer's 
recommendations.  Disruption, homogenization and purification of tissue were 
achieved with mortar and pestle, and QIAshredder columns (Qiagen). To remove 
the proteins which could interfere with the RNA isolation, proteinase K digestion 
(Invitrogen Life Technologies Corporation, Burlington, ON, Canada) was used. 
DNase I treatment was applied on the columns to eliminate any contaminating DNA 
(RNase-free DNase Set, Qiagen,).RNA concentrations were measured by 
spectophotometry, using a NanoDrop ND-1000 spectrophotometer (Nanodrop 
Technologies, Wilmington, DE), and  1 µg of total RNA from each sample was 
reverse transcribed to cDNA using Superscript II Reverse Transcriptase 
(Invitrogen). 
Quantitative real time PCR (qPCR) 
Gene-specific primers for SCARB1, STAR, HSD3B1, CYP11A1, CYP17A1, STS, 
SULT1E1, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and actin, beta 
(ACTB) employed to amplify genes in reverse transcribed samples by qPCR using 
the 7300 Real Time PCR thermal cycler (PE Applied Biosystems, Foster City, Ca, 
USA). Sequences of the primer pairs and expected product sizes are shown in Table 
1. Bovine STAR, CYP11A1, HSD3B1, STS and SULT1E1 primers were designed from 
published bovine sequences [17-20].  CYP17A1, SCARB1, GAPDH and ACTB primers 
were designed based on bovine genes sequences from GenBank, and using the 
Primer Express software Version 3.0 (PE, Applied Biosystems). The qPCR products 
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from CYP17A1, SCARB1 , GAPDH and ACTB were subjected to electrophoresis, and 
then target band was excised and purified using a a QIAquick gel extraction  kit 
(Qiagen) and sequenced (The McGill University and Génome Québec Innovation 
Centre, Montréal, QC). Primer concentrations were optimized according to the 
manufacturer’s recommendations and dissociation curve analysis and agarose gel 
electrophoresis were used to verify the specificity of amplified products. The PCR 
efficiency (E= 1.9-2.0) and linearity of each pair of primers were tested by 
preparing a series of solutions of the same stock of cDNA used for the qPCR gene 
analysis. The geometric mean of two reference genes (GAPDH and ACTB) was used 
as the normalization factor. The relative quantification method (ΔΔC t ) was used to 
determine changes in target gene expression levels [21, 22]. Data analysis was 
performed using the Sequence Detection Software version 1.4 (PE, Applied 
Biosystems) and the LinRegPCR Software version 11.1 (Heart Failure Research 
Center Academic Medical Centre Amsterdam, the Netherlands). Reactions for qPCR 
were conducted in sealed 96-well multiply (Sarstedt Inc., Montréal, QC Canada) in 
triplicate. The total volume of the qPCR reaction was 20 µl, comprising 6 µl cDNA 
template (diluted 1 in 30 in distilled water), 2 µl each forward and reverse primers, 
2 µl of distilled water and 10 µl Power SYBR green PCR master mix (Applied 
Biosystems). Cycling conditions were 2 min at 50°C and 10 min at 95°C, followed by 
40 cycles of 15 sec at 95°C and 60 sec at 60°C.  
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Western Blotting 
Homogenates from SCNT and NG pregnancies were obtained by powdering 
small pieces of frozen cotyledons individually, with mortar and pestle. The samples 
were homogenized in sonication buffer (20 mM Tris, 50 mM EDTA, 0.1 mM DEDTC, 
pH8.0; Invitrogen Life Technologies Corporation, Burlington, ON, Canada and 
Sigma-Aldrich, Oakville, ON, Canada), containing 32mM octyl glucoside and 
protease inhibitor (Complete mini, EDTA-free, Roche, Mannheim, Germany).  The 
lysates were spun by differential centrifugation (600 x g for 30 min, then the 
resultant supernatant was re-centrifuged at 9000 x g for 30 min ) to obtain 
mitochondrial and cytosolic proteins [11].  The protein concentration was 
measured by a Bradford protein assay (Bio-Rad Laboratories, Hercules California, 
USA), adjusting the samples to 70 µg/µl of protein. The proteins were then diluted 
in sample buffer containing 25 mM Tris (pH 6.8), 1 % SDS, 5 % mercaptoethanol, 1 
mM EDTA, 4% glycerol, and 0.01 % bromophenol blue (Invitrogen and Sigma-
Aldrich) and were boiled for five minutes.  Microsomal and mitochondrial fractions 
prepared from cotyledons were size-fractioned on a 12% SDS-polyacrylamide gel 
and then electrotransferred onto PVDF transfer membrane (GE Healthcare, 
Piscataway, NJ). The low and high range molecular weight marker (Amersham 
Biosciences, Little Chalfont, Buckinghamshire, UK Limited) was used as reference.  
The membranes were then blocked with 4 % nonfat dry milk in TBS buffer 
containing 0.5 % Tween 20 (TBST) and incubated with their respective first 
antibody overnight. First and second antibodies were diluted in TBST.  The rabbit 
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anti-human for STAR and ACTB first antibodies (Santa Cruz Biotechnology, Inc. 
Santa Cruz CA), were applied in a 1:300 and 1: 50 000 dilutions respectively. Rabbit 
anti-rat first antibodies for CYP11A1 (Chemicon, International, Temecula,CA, USA) 
and HSD3B1 (Santa Cruz) were used at 1: 1000 and 1:1500 dilutions respectively.  
The second antibody peroxidase-conjugated Affini Pure Goat anti-rabbit IgG 
(Jackson Immuno Research Laboratories Inc, West Grove, PA, USA), was used at 
1:100000 dilutions. Mitochondrial and cytosolic proteins from different 
steroidogenic tissues (mouse adrenal glands and bovine corpus luteum) and non 
steroidogenic organs (bovine lung) were used as positive and negative controls, 
respectively, to validate the system. The optical density was analyzed using ImageJ 
1.31v software (National Institutes of Health, Bethesda MD). 
Immunohistochemical staining procedures 
Paraffin sections of cotyledons were rehydrated and heated in 10 mM 
sodium citrate (pH 6.0) for 20 min for antigen retrieval. The sections were blocked 
with 5% BSA in PBS for 30 min at room temperature, and incubated with the 
respective first antibody. For SCARB1, rabbit polyclonal anti-mouse antibody 
(Novus Biologicals, Littleton, CO) diluted 1:50. A CYP11A1 rabbit anti-rat polyclonal 
antibody (Chemicon, International) diluted 1:200 and a CYP17A1 goat anti-human 
polyclonal antibody (Santa Cruz Biotechnology) diluted 1:100.  Slides were 
incubated with the respective second antibody Cy3-conjugated goat anti-rabbit IgG 
and donkey anti-goat IgG (Jackson Immunoresearch.), diluted 1:400 for 1 h at RT. 
Slides were then washed, and the nuclei were stained with 4',6-diamidino-2-
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phenylindole (DAPI, Sigma, St. Louis, MO), diluted 1:1000 in PBS, for 5 min. Slides 
were mounted in Permafluor (Lab VisionCorp.; Fremont, CA). All antibodies were 
diluted in PBS, and as a negative control, some sections were incubated with BSA in 
the place of the first antibody.  
Placental distributions of the three factors were observed by confocal 
microscopy using the Olympus Fluoview 1000 system and Fluoview version 1.7175 
software. Laser sources of 543 nM and 405 nM were employed for detection of Cy3 
and DAPI signals, respectively. For a given fluorochrome (i.e., CY3 or DAPI), 
photomultiplier voltage, laser power, pinhole aperture, time of acquisition and 
image resolution were maintained constant for all confocal images. The Kalman 
filter mode was used for all image acquisition.  
Statistical Analysis 
Statistical analysis was carried out using SigmaPlot (version 11.2, Systat 
software, Inc. Germany). If data had a normal distribution by Shapiro-Wilk test, a 
parametric (one-way ANOVA and student's t-test) analysis was applied to 
determine differences between groups. When distribution of the data was not 
normal, a non parametric analysis was applied (Wilcoxon/Kruskal-Wallis test, 
Rank Sums). Gene data are presented as mean +SEM, and differences between 
samples were considered significant when p < 0.05. 
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4.7. Tables and figures 
Table 1. Primer pairs used for RNA detection 
 
Genes qPCR primers sequence (5'–3') Fragment 
size (bp) 
References/ 
accession no. 
Primer 
concentration 
ACTB FWD GGATGAGGCTCAGAGCAAGAGA
REV TCGTCCCAGTTGGTGACGAT  
58 NM_173979  FWD 3 µM 
REV  3 µM 
CYP11A1 FWD CTGCAAATGGTCCCACTTCT 
REV  CACCTGGTTGGGTCAAACTT 
209 Murayama et al. 
(2008)/ 
NM_176644   
FWD 9 µM 
REV  1.5 µM 
CYP17A1 FWD CCATCAGAGAAGTGCTCCGAAT 
REV  GCCAATGCTGGAGTCAATGA  
79 NM_174304  FWD 3 µM 
REV  3 µM 
GAPDH FWD 
GGCGTGAACCACGAGAAGTATAA  
REV CCCTCCACGATGCCAAAGT  
100 NM_001034034 FWD 9 µM 
REV  3 µM 
HSD3B1 FWD GCCCAACTCCTACAGGGAGAT 
REV  TTCAGAGCCCACCCATTAGCT 
114 Orisaka et al. 
(2006)/ 
NM_174343.2  
FWD 1.5 µM 
REV  3 µM 
STAR FWD CCCATGGAGAGGCTTTATGA 
REV TGATGACCGTGTCTTTTCCA 
115 Nishimura et al. 
(2006) / 
NM_174189.2  
FWD 9 µM 
REV  3 µM 
SCARB1 FWD GACCCCTTAATCCACCTCATCA 
REV  GGCCAGAATCGGAGTTGTTG  
99 NM_174597.2  FWD 3 µM 
REV  3 µM  
STS FWD  GCCTCCTGCTCGGCTTTC  
REV   TGTTCACGGTTCCGCATCA  
65 Greven et al 
(2007)/DQ532016
.1  
FWD 3 µM 
REV  9 µM  
SULT1E1 FWD CCTGAGTGGGGATTGAAGAA  
REV  CACAGGCAGGTGAGACTTCA  
412 Hirayama et al 
(2008)/NM_1774
88  
FWD 3 µM 
REV  3 µM 
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Figure 1. Characterization of mRNA levels for STAR, CYP11A1, HSD3B1, CYP17A1, 
SCARB1, STS and SULT1E1 in cotyledonary tissue of artificial insemination (AI) and 
somatic cell nuclear transfer (SCNT) gestations at day 40. Bovine ACTB and GAPDH 
served as loading and constitutive control. Results of qPCR are shown as relative 
mRNA expression for each gene normalized to the reference genes. Gray bars 
represent NT group, and white bars represent AI group. Significant differences 
(P<0.05) between NT and AI groups are indicated by an asterisk. (n=4).  
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Figure 2. Immunoblotting analysis for STAR, CYP11A1, HSD3B1 and ACTB in 
cotyledonary tissues at day 40 of gestation. White bars represent non-clone 
gestations (NG), and gray bars represent somatic cell nuclear transfer (SCNT) 
gestations. Bovine ACTB served as loading and constitutive control. (NG=4 and 
SCNT=4).  
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Figure 3.  Immunofluorescence staining of SCARB1 in bovine cotyledons at day 40 
of AI pregnancy. (A and E) Bright field of trophoblast sections. (B and D) SCARB1 
expression is present in the uninucleate trophoblast cells (white arrowhead) and in 
a blood vessel (star). Moreover the SCARB1 expression is greatly reduced or absent 
in the trophoblast giant cells (white arrow). (C and G) Nuclei counterstained with 
DAPI. (F) Negative control.  
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Figure 4.  Immunofluorescence staining of CYP17A1 in bovine cotyledons at day 40 
of AI pregnancy. (A and E) Bright field of trophoblast sections. (B and D) CYP17A1 
expression is scarcely present in the uninucleate trophoblast cells (white 
arrowhead) and absent in the trophoblast giant cells (white arrow). (C and G) 
Nuclei counterstained with DAPI. (F) Negative control.  
 
 
 
 
 
 
 
 
 
137 
 
50
µm
50
µm
50
µm
50
µm
50
µm
50
µm
50
µm
Br
ig
ht
 fi
el
d  
   
   
   
   
   
   
   
   
  
CY
P1
1A
1 
   
   
   
   
   
   
   
D
AP
I  
   
   
   
   
   
   
   
   
   
   
   
   
   
 
M
ER
G
E 
   
   
   
   
   
Negativecontrol
A
B
C
D
E
F
G
 
138 
 
 
 
 
 
 
Figure 5.  Immunofluorescence staining of CYP11A1 in bovine placentome at day 
40 of AI pregnancy. (A and E) Bright field of trophoblast sections. (B and D) 
CYP11A1 expression is in the fetal stromal cells, uninucleate trophoblast cells 
(white arrowhead) and uterine stromal cells (white star). Moreover the expression 
of CYP11A1 is reduced or absent in the trophoblast giant cells (white arrow). (C 
and G) Nuclei counterstained with DAPI. (F) Negative control. 
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Regulation of placental steroid synthesis in bovine placentome 
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5.1. Abstract 
It has previously been demonstrated that the bovine placenta is capable of steroid 
production, which in turn is expected to regulate placental and fetal development. 
The small amount of evidence available suggests that regulation of steroid 
synthesis differs between the placenta and the ovary in this species. Little is known 
about the principal factors and intracellular pathways activating the steroidogenic 
process in bovine placenta. The aim of this study was to investigate the impact of 
trophic homone and second messengers on steroidogenesis in bovine placenta at 
140 +10 days of gestation. Explants of placentome tissue were incubated for 6, 12 
and 18 hours, with human chorionic gonadotrophin (hCG), dibutyryl cAMP 
(dbcAMP), phorbol 12-myristate 13-acetate (PMA), calcium ionophore (A23187), 
and a combination of hCG and A23187.  
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After incubation, progesterone (P4) concentrations in medium were determined by 
RIA. Semiquantitative RT-PCR was used to measure steroid acute regulatory 
protein (STAR), cytochrome P450, family 11, subfamily A, polypeptide 1 (CYP11A1), 
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 
(HSD3B1), sulfotransferase family 1E, estrogen-preferring, member 1 (SULT1E1) 
and steroid sulfatase (STS) gene expression. Gene expression of STAR, CYP11A1, 
HSD3B1 and SULT1E1 were increased in placentome explants stimulated with hCG, 
A23187 and hCG +A23187 in a time-dependent manner. At all periods investigated, 
calcium ionophore had a stimulatory effect on the P4 levels with respect to the 
control group (P<0.05). Our data suggests that the trophic hormone (LH or hCG) 
stimulates the expression of steroidogenic genes in bovine placenta. We conclude 
that in bovine placenta the synthesis of progesterone is modulated principally by 
intracellular calcium influx, and apparently cyclic nucleotides do not seem to be 
controlling this process.  
5.2. Introduction 
Steroid hormones are synthesized in the adrenal gland, gonads, placenta and 
brain, and are critical for normal reproductive function and body homeostasis 
(Manna, Dyson et al. 2009). As in many mammalian species, bovine placenta 
produces estrogens and progesterone (Pimentel, Pimentel et al. 1986; Izhar, 
Pasmanik et al. 1992). Studies suggest that placental estrogens and P4 are 
important factors controlling placental and fetal growth in this species (Schuler, 
Wirth et al. 1999; Hoffmann and Schuler 2002).  Steroid hormone synthesis is a 
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complex process that requires the coordinated expression of several proteins, 
regulated by the activation of different intracellular pathways. Steroidogenic 
endocrine tissues such as the adrenal gland and the gonads respond to trophic 
hormones and other external stimuli with a rapid surge in steroid hormone 
production (Steele and Leung 1992; Saez 1994; Ghayee and Auchus 2007). 
The steroidogenic response is initiated by steroidogenic acute regulatory 
protein (STAR), which acts as the rate-limiting step in steroid biosynthesis, 
regulating the delivery of cholesterol from the outer to the inner mitochondrial 
membrane (Manna, Dyson et al. 2009). Here, the enzyme CYP11A1 is located in the 
mitochondria matrix associated with the inner membrane, cleaves the side of chain 
from cholesterol to form pregnenolone, which is next metabolized to P4 by a 
dehydrogenase, HSD3B1, (Clark and Cochrum 2007; Rekawiecki, Kowalik et al. 
2008; Lavoie and King 2009). Pregnenolone and P4 are considered the basic 
precursors of other steroid hormones as aldosterone, cortisol, testosterone, 
estrone and estradiol (Lavoie and King 2009). However, the enzyme SULT1E1 
regulates the availability of free estrogens by sulfoconjugation; and the STS enzyme 
produces estrogen sulphates, which may serve as substrates for the production of 
free estrogens (Reed, Purohit et al. 2005; Pasqualini 2009).   
Our previous findings demonstrated the expression of the three principal 
steroidogenic markers (STAR, CYP11A1 and HSD3B1) in bovine placenta during 
the first half of the gestation (unpublished).  Steroidogenesis in the gonads and 
adrenal glands is predominantly mediated through the interaction of luteinizing 
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hormone (LH) and adrenocortocotropic hormone (ACTH), respectively. LH and 
ACTH bind to specific membrane receptors, which results in the activation of 
coupled G proteins in their target tissues, with the consequence of intracellular 
modifications including the activation of cAMP-dependent protein kinase A (PKA) 
and protein kinase C (PKC) pathways (Nishikawa, Sasano et al. 1996; Luo, Chen et 
al. 1998; Rekawiecki, Nowik et al. 2005; Miller 2007). Nevertheless, other factors 
such as epidermal growth factor (EGF), insulin-like growth factor 1(IGF1), prolactin 
(PRL), gonadotrophin-releasing hormone 1 (GNRH1) and macrophage-derived 
factor (MDF) have been demonstrated to function in the regulation of steroid 
biosynthesis in gonads and adrenal glands (Weiss-Messer, Ber et al. 1996; Sekar, 
Lavoie et al. 2000; Hales 2002; Manna, Dyson et al. 2009). In addition, calcium 
(Ca2+) signaling has been shown to be involved in the modulation of 
steroidogenesis (Cherradi and Capponi 1998; Yamazaki, Kawasaki et al. 2006; 
Manna, Dyson et al. 2009). However, there is no report describing the principal 
intracellular pathways and factors implicated in the regulation of the steroidogenic 
process in bovine placenta. 
Thus, the goal of this current study was to assess whether hCG and multiple 
second messenger systems (dbcAMP, PMA and calcium ionophore) regulate the 
steroidogenic process and the synthesis of progesterone in bovine placenta. In the 
present study, we investigated the influence of the aforementioned factors upon 
the expression of genes (STAR, CYP11A1, HSD3B1, SULT1E1 and STS) implicated in 
the synthesis of steroid hormones.  
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5.3. Material and methods  
Placental samples  
Bovine placentas at 140 +10 days of gestation were collected from normal 
gestations at a local abattoir (n=3). Gestational age was determined by fetal crown-
rump length (CRL) based on the Riding (18) and Evans and Sack charts(Evans and 
Sack 1973; Riding, Lehnert et al. 2008). 
Study design  
We developed a placentome explant model of bovine gestation around days 
140 +10 based on previous studies with human and equine placental explants 
(Fuglsang, Moller et al. 2008; Nash, Lane et al. 2008). Moreover, preliminary 
studies were performed to validate the functionality and viability of placentome 
explants; and also to establish the optimal culture conditions. 
Tissue culture   
The pregnant uteri were placed on ice for transport. Placental tissues were 
washed and dissected under sterile conditions in Dulbecco's Modified Eagle 
Medium (DMEM) (1X), high glucose (Invitrogen Life Technologies Corporation, 
Burlington, ON, Canada). Three placentomes per placenta were collected and used 
as independent replicates, and treatments were performed in triplicate for each 
treatment. The placentomes were chopped transversely (to maintain the 
caruncular-cotyledonary union) into small fragments (approximately 300 + 20 mg 
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wet weight) using a tissue slicer (Thomas Scientific, Swedesboro, NJ ,U.S.A.). The 
tissue explants were placed in six-well tissue culture plates, and were incubated in 
DMEM supplemented with 10% of fetal bovine serum (FBS, Invitrogen-GIBCO) and 
antibiotics (100 U/ml penicillin and 100 µg/ml streptomycin) at 37 ◦C in a 
humidified atmosphere of 95% air and 5% CO2.  To reduce the influence of growth 
factors and steroids in the explants, FBS was treated with charcoal/dextran 
(Lindquist and de Alarcon 1987).  
Treatments and sampling  
After a 2 hour (h) conditioning period, the medium was removed and 
replaced with fresh medium (control), or medium containing the appropriate 
treatment for 18 h. Dimethyl sulphoxide (DMSO, Sigma-Aldrich, St Louis, MO, USA) 
was used as a carrier agent in all treatments including the control group. Tissues 
were treated with 1mM of dbcAMP (Sigma-Aldrich,), 10 nM  of  PMA (Sigma-
Aldrich,), 1 µg/ml of hCG (Calbiochem EMD Bosciences Inc, La Jolla, CA, USA ), 10 
µg/ml of A23187 (Sigma-Aldrich,), and a combination of  hCG +A23187 (1 µg/ml 
and 1 µg/ml respectively).  In cattle it was demostrated that hCG mimics the action 
of LH, inducing ovulation and then the formation of a functional CL (Price & Webb, 
1989; Rajamahendran & Sianangama, 1992; Schmitt, et al., 1996). Moreover hCG 
acts independently of the pituitary gland and has a longer life (16 h) than natural 
LH (Haour & Saez, 1977; Kinser, et al., 1983). 
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Before determining the effect of the hCG, on steroid synthesis in placental 
explants; the presence of mRNA LH receptor in bovine caruncles and cotyledons 
was evaluated using tissue from bovine corpus luteum (CL) as a positive control. 
Culture medium and tissue samples from each explant were collected at 0, 6, 12 
and 18 h (T0, T6, T12 and T18) after treatment and stored at -20ºC and -80 ºC until 
measurement of P4 levels and qPCR analysis, respectively. Treatment 
concentrations and sampling frequency were determined based on previous 
studies (Sekar, Lavoie et al. 2000; Rekawiecki, Nowik et al. 2005; Bamberger, 
Briese et al. 2006; Manna, Jo et al. 2007), and in P4 levels found in pilot studies.  
Hormone assay  
Concentrations of P4 in culture medium were evaluated by 
radioimmunoassay according to previously described procedure (Pescador, Houde 
et al. 1997; Ruiz-Cortes, Martel-Kennes et al. 2003).  The progesterone 
concentrations were calculated as pg/ml per 1 mg of tissue. The P4 tracer was 
purchased from PerkinElmer (NET 381250UC, Waltham, Massachusetts, USA) and 
the P4 antibody was gently provided by Dr. Gordon Niswender, Colorado State 
University. The intra-assay and inter-assay were on average 3.38% and 4.75% 
respectively.  
RNA isolation and Quantitative real time PCR (qPCR) 
Total RNA was extracted from cultured tissues, using an RNeasy Mini Kit 
(Qiagen Mississauga, ON, Canada), according to the manufacturer's 
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recommendations.  Disruption, homogenization and purification of tissue were 
achieved with mortar and pestle, and QIAshredder columns (Qiagen). To remove 
the proteins which could interfere with the RNA isolation, proteinase K digestion 
(Invitrogen) was used. DNase I treatment was applied on the columns to eliminate 
any contaminating DNA (RNase-free DNase Set, Qiagen,). Amounts of RNA were 
quantified by spectophotometry, using a NanoDrop ND-1000 spectrophotometer 
(Nanodrop Technologies, Wilmington, DE), and  1 µg/sample of total RNA was 
reverse transcribed to complementary DNA (cDNA) using Superscript II Reverse 
Transcriptase (Invitrogen). 
The abundance of transcripts for luteinizing hormone/choriogonadotropin 
receptor (LHCGR), STAR,HSD3B1, CYP11A1, STS, SULT1E1, glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) and actin, beta (ACTB) were quantified by 
qPCR using the 7300 Real Time PCR thermal cycler (Applied Biosystems Foster 
City, Ca, USA ). Table 1 shows the sequences of the primer pairs and product sizes.  
Bovine LHCGR, STAR, CYP11A1, HSD3B1, STS and SULT1E1 primers were designed 
from published bovine sequences (Shemesh, Gurevich et al. 1997; Nishimura, 
Sakumoto et al. 2006; Orisaka, Tajima et al. 2006; Greven, Kowalewski et al. 2007; 
Hirayama, Sawai et al. 2008; Murayama, Miyazaki et al. 2008). CYP17A1, GAPDH 
and ACTB primers were designed based on bovine genes sequences from GenBank, 
using the Primer Express software Version 3.0 (PE Applied Biosystems).The qPCR 
products from CYP17A1, GAPDH and ACTB were validated by sequencing (The 
McGill University and Génome Québec Innovation Centre, Montreal, QC). Primer 
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concentrations were optimized according to the manufacturer’s recommendations 
(Applied Biosystems) and dissociation curve analysis and validated by 
electrophoresis. The PCR efficiency (E= 1.9-2.0) and linearity of each primer were 
tested by preparing a series of solutions of the same stock of cDNA used for the 
qPCR gene analysis. The geometric mean of two reference genes (GAPDH and 
ACTB) was used as a normalization factor. Relative quantification method (ΔΔC t) 
was used to determine changes in target gene expression levels (Livak and 
Schmittgen 2001; Pfaffl 2001). Data analysis was performed using the Sequence 
Detection Software version 1.4 (PE Applied Biosystems) and the LinRegPCR 
Software version 11.1 (Heart Failure Research Center Academic Medical Centre 
Amsterdam, the Netherlands). Reactions for qPCR were conducted in sealed 96-
well multiply (SARSTEDT INC, Montreal, Canada) in triplicate. The total volume of 
the qPCR reaction was 20 µl, comprising 6 µl cDNA template (diluted 1 in 30 in 
distilled water), 2 µl each forward and reverse primers, 2 µl of distilled water and 
10 µl Power SYBR green PCR master mix (Applied Biosystems,). Cycling conditions 
were 2 min at 50°C and 10 min at 95°C, followed by 40 cycles of 15 sec at 95°C and 
60 sec at 60°C.   
Pilot studies 
The aims of the pilot studies were to establish the concentrations and timing 
of sampling collection during experimental treatments, based in the progesterone 
levels. Placentome explants were treated with three different concentrations of 
each treatment solution: dbcAMP (10 µM, 100 µM and 1 mM), PMA (1 nM, 10 nM 
149 
 
and 100 nM), hCG (10 ng/ml, 100 ng/ml and 1µg/ml) and A2387 (100 ng/ml, 
1µg/ml 10 µg/ml). The timing of sampling collection for the treatments was 1 and 6 
h post-treatment and there P4 concentrations in culture medium were determined 
by RIA. The placentome culture conditions and RIA were done by the above-
mentioned methods. Figure 1 shows the treatments, concentrations and sampling 
times.  
Statistical Analysis 
Progesterone concentrations and gene expression are represented as means 
+ standard error (±S.E.M.). Each experiment was performed in triplicate and 
statistical analysis was carried out using SigmaPlot (version 11.2, Systat software, 
Inc. Germany). A normal distribution (Shapiro-Wilk test) was performed before a 
parametric analysis. One-way ANOVA and Dunnett's Method were applied to 
determine significant differences (P < 0.05) between treatments versus control 
group. For pilot studies a Kruskal-Wallis One Way Analysis of Variance on Raks and 
Dunn's Method were used.    
5.4. Results 
In the pilot studies, treatments with dbcAMP, PMA and hCG at different 
concentrations did not affect the progesterone levels in culture medium with 
respect to the control group of any studied times. Conversely a high dose 
(10µg/ml) of A2387 consistently led to increase P4 content in the culture media at 
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1 and 6 hours after treatment (Figure 1).  Based on the aforementioned results we 
chose the best concentrations for the present study.   
Steroidogenic genes expression 
PCR demonstrated that the LHR mRNA is present in the bovine placenta, 
(caruncles and cotyledons) (Fig.2). qPCR method was used to test whether 
dbcAMP, PMA, hCG, A23187 and hCG +A23187 affect the expression of 
steroidogenic markers in placental explants. Concentrations of mRNA for CYP11A1 
were higher (P<.01) after treatment with hCG, A23187 and hCG +A23187, and with 
hCG and A23187 at time 6 h and 12h respectively (Figure 3).  Moreover mRNA for 
HSD3B1 increased (P<.05) after A23187 and hCG +A23187 treatments at 6h; and 
with hCG, A23187 and hCG +A23187 at 12 h post treatment (Figure 3). Figure 4 
illustrates the stimulatory impact of exposure to hCG, A23187 and hCG +A23187 on 
SULT1E1 mRNA expression at time 6 h and 12 h; and to hCG at time 18 h. The 
CYP11A1, HSD3B1 and SULT1E1 mRNA expression was decreased in the A23187 
group, 18 h after treatment (Figure 3 and 4) (P<.05). None of the treatments had an 
impact in the (mRNA) STS expression at all investigated periods (Figure 4).  As 
shown in figure 5-A, hCG, A23187 and hCG +A23187 significantly increased (P<.05) 
STAR mRNA after 18 h of incubation. 
Progesterone concentrations 
Only calcium ionophore stimulated the secretion of progesterone levels 
(P<.001) in culture media at all times investigated (Figure 5-B). P4 concentrations 
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after hCG and hCG +A23187 treatments appeared to be higher compared with 
control group at all periods, however no significant differences were observed.  
Apparently, the second messenger analogs dbcAMP and PMA did not alter the 
progesterone levels or the expression of any of the steroidogenic genes analyzed. 
5.5. Discussion 
It is well known that bovine placenta produces estrogens and progesterone 
(Hoffmann and Schuler 2002) but, despite extensive study, the mechanisms of 
steroidogenesis in the bovine placenta remain unclear. In our previous studies, we 
investigated the expression of the principal steroidogenic markers (STAR, CYP11A1 
and HSD3B1) in bovine placenta, and also the principal cells implicated in the 
steroidogenic process  in bovine placenta during the first half of pregnancy 
(Verduzco, Fecteau et al. 2010). The purpose of these experiments was to elucidate 
the principal factors implicated in the control of placental steroidogenesis. 
In the present experiment, even if no significant differences were found on P4 
concentrations after hCG and hCG +A23187 treatments, the P4 levels tended to be 
higher compared with control group at all periods. Furthermore a significant 
increase in STAR, CYP11A1 and HSD3B1 gene expression stimulated by hCG was 
observed at different sampling times. These observations are wholly consistent 
with those reported by other authors, which found that LH stimulated secretion of 
P4 and increased the STAR, CYP11A1and HSD3B mRNA and protein expression in 
bovine luteal cells, mouse Leydig tumor cells (MA-10), human luteal cells and 
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porcine granulosa-luteal cells (Ravindranath, Little-Ihrig et al. 1992; Ivell, Tillmann 
et al. 2000; Sekar, Lavoie et al. 2000; Hauet, Yao et al. 2005; Rekawiecki, Nowik et 
al. 2005).  
In cattle, the preovulatory surge of LH is necessary for the luteinization of 
follicular cells and for CL maintenance (Rekawiecki, Kowalik et al. 2008). The 
presence of LHR has been shown in a very wide range of bovine tissues such: ovary, 
adrenal glands, endometrium, myometrium, uterine blood vessels, cervix and 
uterine veins (Little, Rahe et al. 1982; Schallenberger, Rampp et al. 1985; Shemesh, 
Gurevich et al. 1997), but the presence of (mRNA) for LH receptors in placenta 
appear not to have previously been shown. In human, placental expression of the 
LH receptors in trophoblast cells, cytotrophoblasts and syncytiotrophoblast have 
been reported (Pidoux, Gerbaud et al. 2007). In our understanding the present 
work demonstrated for the first time that the LHR mRNA is present in bovine 
placenta, however, western blot and binding assays will be required to authenticate 
the presence of the LHR in bovine placenta. 
Surprisingly, and contrary to the notion that binding of LH to its cell-surface 
G protein-coupled receptor activates adenylyl cyclase resulting in activation of 
cAMP-dependent protein kinase (PKA) to stimulate P4 synthesis (Rekawiecki, 
Kowalik et al. 2008); in the present study hCG treatment increased the expression 
of steroidogenic markers but not the P4 levels. Moreover, in the present report 
placental explants treated with dbcAMP did not have any impact in the P4 levels 
and neither in the expression of steroidogenic genes. These findings suggest that 
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LH and its second messenger cAMP, apparently are not the principal factors that 
control the steroidogenic process in bovine placenta. In this regard, some authors 
found that during bovine pregnancy LH concentrations decreased as pregnancy 
progress (Little, Rahe et al. 1982; Schallenberger, Rampp et al. 1985), and 
apparently luteal progesterone secretion at day 200 of gestation, is done via 
prostaglandin E1 (PTG E1) and prostaglandin E1 (PTG E2) , and not via LH (Weems, 
Lammoglia et al. 1998).  
An extensive amount of evidence indicates that trophic hormones can also 
activate the protein kinase C (PKC) signaling pathway (Manna, Jo et al. 2007; 
Manna, Dyson et al. 2009; Manna, Huhtaniemi et al. 2009) (Morley, Hobkirk et al. 
2000; Rekawiecki, Kowalik et al. 2008).  Nonetheless, in the present study we 
observed that P4 concentrations and genes involved in steroidogenesis were not 
affected by PMA treatment. PMA is a phorbol ester activator that acts as a second 
messenger analogue in the PKC pathway (Niedel, Kuhn et al. 1983; Ballester and 
Rosen 1985).  
These results imply that in bovine placenta, P4 synthesis could be 
modulated by cAMP and PKC independent pathways. In this context, some authors 
found that activation of extracellular-signal-regulated kinases (ERK)/mitogen 
activated protein kinase (MAPK) and P13K/Akt pathways, modulate the synthesis 
of steroids in bovine granulosa and theca cells (Tajima, Yoshii et al. 2005; Fukuda, 
Orisaka et al. 2009).  Moreover LH has been shown to stimulate PLC- inositol 
phosphate pathway by inositol phosphate accumulation and intracellular Ca2+ in 
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bovine luteal cells (Nishimura, Shibaya et al. 2004) (Davis, May et al. 1996). In this 
regard, in our experiment, calcium ionophore was the only treatment that 
significantly increased P4 concentrations with respect to the control group. We also 
observed an increase in mRNA abundance of STAR at 18 h of treatment and in 
mRNA abundance of CYP11A1 and HSD3B1 after 6 h and 12 h of treatment in the 
explants cultures treated with A23187. These findings concur with a previous 
investigation in bovine placenta, where authors examined the effects of the calcium 
ionophore on P4 formation, and found that this drug enhanced progesterone 
formation (Shemesh, Hansel et al. 1984).  Our data support the hypothesis 
proposed by the aforementioned authors, that progesterone synthesis in the bovine 
placentome is calcium dependent and cyclic nucleotide independent. In human 
placenta, calcitriol, which results from the conversion of 25-hydroxyvitamin D3 
(25-OHD3) into 1,25-dihydroxyvitamin D3 (calcitriol) promotes calcium transport 
in the placenta and is a physiological regulator of steroidogenic enzymes, and 
consequently stimulates estrogens and P4 synthesis (Dusso, Brown et al. 2005; 
Barrera, Avila et al. 2007) .  
It would be conceivable that calcium influx either directly or indirectly is 
regulated by other factors and mechanisms. In fact, PGE(1), PGE(2), epidermal 
growth factor (EGF), insulin-like growth factor (IGF), prolactin (PRL), 
gonadotrophin-releasing hormone (GnRH) and macrophage-derived factors 
(MDFs) have been demonstrated to function in the regulation of steroid 
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biosynthesis in gonads and adrenal glands (Weiss-Messer, Ber et al. 1996; Sekar, 
Lavoie et al. 2000; Hales 2002; Manna, Dyson et al. 2009). 
In our studies, we did not observe a synergistic or additive effect of hCG and 
calcium ionophore (hCG +A23187), however, we used a lower dose of calcium 
ionophore for the hCG +A23187 than in A23187 treatment alone. For that reason 
we cannot exclude the possibility that LH could act concomitantly with calcium, 
increasing the expression of stereroidogenic genes and the P4 synthesis. 
Treatment of explants cultures with hCG, A23187 and hCG +A23187 
increased mRNA abundance for SULT1E1 for almost all studied periods. This is the 
first evidence linking increased SULT1E1 expression to LH and calcium influx. 
Estrogen sulfotransferase is a metabolic enzyme that transforms active estrogens 
into sulfoconjugated estrogens which then lose their ability to interact with the 
estrogen receptor and are hormonally inactive.  Sulfated estrogens act as regulators 
to attenuate the local estrogen response, and they could also be precursors of the 
production of free estrogens depending, on estrogen sulfatase activity (Rossier and 
Pierrepoint 1974). Non-specific stimulatory effects on (mRNA) STS expression 
were observed at any treatment.  Previously, it was demonstrated that SULT1E1 is 
expressed in cotyledonary tissue from midgestation to parturition (Hoffmann, 
Falter et al. 2001), however, there is lack of data about the mechanisms that control 
this enzyme in bovine placenta. In mouse Leydig cells estrogen sulfotransferase 
expression is under control of LH (Song, Qian et al. 1997; Qian and Song 1999), but 
the regulation of this enzyme by LH in placenta is not clear. In addition, in guinea 
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pigs, estrogen sulfotransferase is detectable in uterus and chorion, and is 
stimulated by the presence of Mg2+, Ca2+ or Mn2+ (Freeman, Saidi et al. 1983).  
Interestingly, in the present experiment the stimulatory influence of A23187 on 
CYP11A1, HSD3B1 and SULT1E1 gene expression decreased significantly at time 18 
h compared to the control group. The abundance and stability of mRNA is 
determined by multiple processes, including fluctuations in their half-lives in 
response to developmental environmental stimuli like nutrient levels, cytokines, 
hormones and temperature shifts as well as environmental stresses such as 
hypoxia, hypocalcemia, viral infection, and tissue injury (Guhaniyogi and Brewer 
2001). In the present study, the decline in the mRNA might have been due to half-
life in the target mRNAs, whose expression may have been controlled by regulating 
mRNA turnover of the steroidogenic genes in response to calcium stimulus. Further 
critical analysis of the data along with the performance of additional analyses of 
different samples will be required to corroborate this phenomenon confidently.  
Although we did not measure the protein abundance of each steroidogenic 
protein, the mRNA expression levels of StAR, CYP11A1 and HSD3B1 stimulated by 
calcium ionophore are expected to be a gross indicator of the changes in 
progesterone found in this experiment, because these three proteins are 
fundamental to P4 synthesis. Conversely, in the present study, we did not measure 
concentrations of estrone sulphate in culture media, and for that reason additional 
studies will be required to confirm the stimulatory action of LH and calcium in 
bovine placenta to produce sulfoconjugated estrogens. 
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In conclusion, hCG alone or in combination with calcium influx, increases 
mRNA of steroidogenic genes but not P4 levels. The second messenger analogues 
dbcAMP and PMA did not have an impact in the steroidogenic process in bovine 
placental explants, but calcium ionophore exerted a genomic regulatory effect by 
increasing the transcript abundance of steroidogenic genes, and stimulating P4 
biosynthesis in placental explants. Taken together, the data point that calcium has a 
pivotal role for intracellular signaling in the steroidogenic biosynthesis in bovine 
placenta. Additional studies will be necessary to unravel the exact mechanism by 
Ca2+ the steroid synthesis in bovine placenta. 
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5.7. Tables and figures  
Table 1. Primer pairs used for RNA detection  
Genes  qPCR primers sequence (5'–3')
 
Fragment size 
(base pairs)  
References/accessi
on no.  
Primer 
concentration  
ACTB FWD GGATGAGGCTCAGAGCAAGAGA 
REV TCGTCCCAGTTGGTGACGAT  
58 NM_173979 FWD 3 µM 
REV  3 µM  
 
CYP11A1 
 
FWD CTGCAAATGGTCCCACTTCT 
REV  CACCTGGTTGGGTCAAACTT 
209 
 
Murayama et al. 
(2008)/ NM_176644   
 
FWD 9 µM 
REV  1.5 µM 
 
CYP17A1 
 
FWD CCATCAGAGAAGTGCTCCGAAT 
REV  GCCAATGCTGGAGTCAATGA  
79  
 
NM_174304  
 
 
FWD 3 µM 
REV  3 µM 
 
GAPDH 
 
FWD GGCGTGAACCACGAGAAGTATAA 
REV CCCTCCACGATGCCAAAGT  
100 NM_001034034 
 
FWD 9 µM 
REV  3 µM 
 
HSD3B1 
 
FWD GCCCAACTCCTACAGGGAGAT 
REV  TTCAGAGCCCACCCATTAGCT 
114 
 
Orisaka et al. (2006)/ 
NM_174343.2  
 
FWD 1.5 µM 
REV  3 µM 
 
LHCGR 
 
FWD  CACCCTCACAGTCATCACAC  
REV  CTCAGCAACAGAAAGAAATC  
552  
 
Shemesh et al. 
(1997)/NM_174381.
1  
 
FWD 10 µM 
REV  10 µM 
 
STAR 
 
FWD CCCATGGAGAGGCTTTATGA 
REV TGATGACCGTGTCTTTTCCA 
115 
 
Nishimura et al. 
(2006) / 
NM_174189.2  
 
FWD 9 µM 
REV  3 µM 
 
STS 
 
FWD GCCTCCTGCTCGGCTTTC  
REV  TGTTCACGGTTCCGCATCA  
65  
 
Greven et al 
(2007)/DQ532016.1  
 
FWD 3 µM 
REV  9 µM  
 
SULT1E1 
 
FWD CCTGAGTGGGGATTGAAGAA  
REV  CACAGGCAGGTGAGACTTCA 
412  
 
Hirayama et al 
(2008)/NM_177488  
 
FWD 3 µM 
REV  3 µM 
FWD: forward. REV: reverse. 
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Figure 1. Pilot studies to determine the influence of different concentrations of 
dbcAMP, PMA, hCG and A2387 on P4 concentrations in bovine placental explants 
after 1 and 6 hours post-treatment. Values are expressed as means + S.E.M for P4 
synthesis by two placentomes per each placenta (one placenta per treatment) 
around day 140 +10 of gestation. Significant differences (P<0.05) between control 
group and treatments are indicated by an asterisk. Bold letters in treatments 
legends represent the best concentration.  
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552 bp
1               2                  3               4
 
 
 
Figure 2. Quantification of LHR gene expression. RT-PCR was performed using pool 
of mRNA extracted from corpus luteum (lane 1), caruncular (lane 2) and 
cotyledonary tissues (lane 3) from 3 cows.  Placental samples were obtained from 
gestations around day 50 to 120. Lanes 1 and 4 represent positive and negative 
control respectively. PCR products of qPCR amplification (estimated 552 bp) were 
stained with ethidium bromide and separated on agarose gel. bp: base pairs. 
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Figure 3. Expression of CYP11A1 and HSD3B1 mRNA in bovine placental explants 
around day 140 +10 of gestation. Explants were treated for 6, 12 and 18 h with 
dbcAMP (1 mM), PMA (10 nM), hCG (1 µg/ml), A23187 (10 µg/ml) and hCG 
+A23187 (1 µg/ml and 10 µg/ml). Significant differences (P<0.05) between  control 
group and treatments are indicated by an asterisk. The data are expressed as the 
mean + S.E.M for CYP11A1 and HSD3B1 mRNA expression in three placentomes 
per each placenta (3 placentas per treatment). Results are shown as relative mRNA 
expression for each gene normalized to the reference genes (ACTB and bovine 
GAPDH).  
 
 
 
 
 
 
 
 
 
 
172 
 
0
0.
51
1.
52
2.
53
T
im
e 
0
T
im
e 
6
T
im
e 
12
T
im
e 
18
SULT1E1 expression
*
*
*
*
*
*
*
*
SU
L
T1
E1
0
0.
2
0.
4
0.
6
0.
81
1.
2
1.
4
1.
6
Ti
m
e 
0
T
im
e 
6
Ti
m
e 
12
Ti
m
e 
18
STS expression
*
ST
S
C
on
tro
l  
   
   
db
cA
M
P
PM
A
   
   
  h
C
G
A
23
18
7 
   
   
 h
C
G
+A
23
18
7
 
173 
 
 
 
Figure 4. Expression of SULT1E1 and STS mRNA in bovine placental explants 
around day 140 +10 of gestation. Explants were treated for 6, 12 and 18 h with 
dbcAMP (1 mM), PMA (10 nM), hCG (1 µg/ml), A23187 (10 µg/ml) and hCG 
+A23187 (1 µg/ml and 10 µg/ml). Significant differences (P<0.05) between  control 
group and treatments are indicated by an asterisk. The data are expressed as the 
mean + S.E.M for SULT1E1 and STS mRNA in three placentomes per each placenta 
(3 placentas per treatment). Results are shown as relative mRNA expression for 
each gene normalized to the reference genes (bovine ACTB and bovine GAPDH). 
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Figure 5. STAR mRNA abundance and P4 concentrations in placentome explants 
around day 140 +10 of gestation.  STAR mRNA abundance (Panel A) and P4 levels 
(Panel B) at 6, 12 and 18 h post-treatment .Placentome explants  from 3 bovine 
gestations around day 140 +10  treated with dbcAMP (1 mM), PMA (10 nM), hCG (1 
µg/ml), A23187 (10 µg/ml) and hCG +A23187  (1 µg/ml and 10 µg/ml). The data 
are expressed as the mean + S.E.M for STAR mRNA expression and P4 synthesis in 
three placentomes per each placenta (3 placentas per treatment). Significant 
differences (P<0.05) between control group and treatments are indicated by an 
asterisk. Results of qPCR (5-A) are shown as relative mRNA expression for each 
gene normalized to the reference genes. Bovine ACTB and GAPDH served as loading 
and constitutive control. 
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CHAPTER 6. GENERAL DISCUSSION 
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Although the physiological role of steroids in gonads and adrenal glands has 
been studied extensively in cattle, the biological role of placental steroids and the 
principal factors and intracellular pathways implicated in the steroidogenic process 
in bovine placenta are still not completely understood.  
In the cow, corpus luteum is the main source of progesterone, which is 
essential for establishing and maintaining pregnancy (Estergreen, et al., 1967; 
Chew, et al., 1979).  Nevertheless, some studies demonstrated that bovine 
pregnancy could survive luteolysis and ovariectomy during the last 70 days of 
gestation (Day, 1977; Chew, et al., 1979), indicating that the placenta could provide 
the steroid support required for the maintenance of gestation. For many years this 
concept was discarded, because levels of progesterone in uterine arteriovenous 
system in bovine placenta apparently had not been altered (Comline, et al., 1974; 
Ferrell, et al., 1983). Subsequent in vitro studies demonstrated that bovine 
placental cells were capable of producing estradiol, estrone and progesterone in 
late gestation (Evans & Wagner, 1981; Gross & Williams, 1988; Matamoros, et al., 
1994). Furthermore, some enzymes and proteins, that are pivotal in the production 
of steroid hormones have  been detected in bovine placental tissue in late gestation 
and at parturition (Gross & Williams, 1988; Pescador, et al., 1996; Pilon, et al., 
1997; Takagi, et al., 2007). However, very little is known about the production of 
these hormones in early pregnancy. In addition, placental abnormalities in cattle 
following inappropriate steroid synthesis in bovine placenta have not been yet 
demonstrated.  
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The overall purpose of this research was to better understand the 
regulatory mechanisms of steroidogenesis in bovine placenta during early 
gestation. In addition, we investigated whether inappropriate synthesis of steroid 
hormones could lead to placental abnormalities reported in SCNT pregnancies. 
The major findings of this thesis are summarized as follows: 
 
1. The maternal and fetal cells involved in steroid hormone biosynthesis from day 
50 to day 120 of pregnancy were identified. 
2. Alterations in the expression of some steroidogenic proteins and genes in SCNT 
derived placenta at day 40 of pregnancy were described. 
3. The factors controlling the synthesis of progesterone in bovine placentome 
explants at 140 +10 days of gestation were investigated.  
Identification of the maternal and fetal cells involved in steroid hormone 
biosynthesis from day 50 to day 120 of pregnancy (Chapter III and IV)    
In the chapter III (first article) we determined the principal cells implicated 
in the placental steroid synthesis and we investigated the expression of candidate 
steroidogenic proteins (STAR, CYP11A1and HSD3B1) in bovine placentomes from 
day 50 to day 120 of pregnancy. The expression of the aforementioned proteins led 
us to determine, if progesterone or its precursor, pregnenolone, could be produced 
by bovine placenta in early gestations. We used techniques that included 
immunohistochemistry, quantitative PCR (qPCR) and immunoblot to achieve this 
objective.  
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Immunohistochemistry results showed the presence of the three 
steroidogenic proteins at interdigitations of the feto-maternal interface at all 
periods investigated.  Moreover, the principal cells that expressed all the markers 
were the uninucleate trophoblast cells and the caruncular epithelial cells. In 
contrast to the notion that in bovine placenta the steroids are produced by the 
trophoblast giant cells (Reimers, et al., 1985; Wooding, 1992), our results 
demonstrated that in early gestation these cells do not participate directly in 
pregnenolone or progesterone synthesis.  The evidence for this conclusion was the 
lack of expression of any of the three steroidogenic markers.  Transcripts and 
protein abundance of the steroidogenic markers were analyzed separately in 
caruncular and cotyledonary tissues.  Protein and mRNA of STAR and CYP11A1 
were found in caruncles and cotyledons from 50 to 120 days of gestation.  In 
contrast, HSD3B1 protein expression was only found in caruncles. It therefore 
seems that the sites of synthesis of placental steroids differ from other species. In 
rodents and mice, steroidogenic markers (STAR, CYP11A1 and HSD3B1) are 
expressed in the fetal side specifically in the trophoblast giant cells, while HSD3B1 
appears only transiently in the maternal deciduas (Arensburg, et al., 1999).  
Our results suggest that even if the two placental compartments have the 
capacity to synthesize pregnenolone, the only compartment capable to produce 
progesterone is the maternal (caruncle).  Moreover, a complementary pattern in 
expression of STAR and CYP11A1 proteins between caruncular and cotyledonary 
tissues across gestation was observed in the present study. These data show that 
apparently there are clear functional distinctions in terms of steroidogenic capacity 
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of caruncles and cotyledons of the bovine placenta.  The findings of our experiment 
open new perspectives on the requirement of cell to cell communication between 
the maternal and fetal cells to produce steroid hormones, and further research is 
needed to identify the underlying processes on a molecular level. 
In Chapter IV (second article), we evaluated the presence of SCARB1, 
CYP11A1 and CYP17A1 in bovine cotyledons at day 40 of gestation using 
immunohistochemistry.  The overall purpose of this evaluation was to determine 
the presence at cellular level of the abovementioned receptor and enzymes, all of 
which are involved in the selective absorption of cholesterol, and in the synthesis of 
pregnenolone, androgens and some steroid precursors.    
Protein localization of SCARB1, CYP11A1 and CYP17A1 was restricted to 
uninucleate trophoblast cells indicating that in cotyledons, these are the main cell 
type responsible for selective absorption of cholesterol into the cell, and also for 
pregnenolone and estrogen precursor synthesis in early gestation.  These results 
agree partially with some reports (Ben-David & Shemesh, 1990; Schuler, et al., 
2006) in bovine placenta, which demonstrated that CYP17A1 and CYP11A1 were 
exclusively found in the uninucleate trophoblast cells.  To our knowledge, this is the 
first time that SCARB1 was examined in bovine placenta.  Furthermore, the results 
of the present study are of interest in advancing our current understanding of how 
cholesterol absorption and steroid synthesis is achieved in cotyledonary tissue at 
day 40 of pregnancy.  
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Taken together, this study provides new information into the cellular origin 
of placental steroid synthesis, and the steroidogenic capacity of the feto-materno-
placental unit from day 50 to day 120 of pregnancy.  
Alterations in the expression of some steroidogenic proteins and genes in SCNT 
derived placenta at day 40 of pregnancy (Chapter IV) 
The cloning of cattle by SCNT has been strongly associated to placental 
abnormalities, which can cause early and fetal losses (Hill, et al., 2000; Heyman, et 
al., 2002; Kohan-Ghadr, et al., 2008). Despite the fact that placental steroids are 
important factors controlling placental and fetal growth in different species, no 
reports have appeared documenting altered expression of steroidogenic proteins 
and enzymes in SCNT bovine placenta.  
In the second manuscript (Chapter IV), we compared the expression of a 
series of genes and proteins coding for steroidogenic proteins between SCNT and 
non-clone pregnancies in cotyledonary tissue at day 40.  Using qPCR, we identified 
a significant reduction in the abundance of transcripts for STAR, CYP11A1, 
HSD3B1, CYP17A1 and SULT1E1 in placentas from SCNT compared to AI 
gestations. Previous studies, reported deregulation of imprinted and non-imprinted 
genes, essential in the regulation of placentogenesis, fetogenesis, angiogenesis, 
mammogenesis, steroidogenesis, and immune system activity in the SCNT bovine 
gestations (Hashizume, et al., 2002; Patel, et al., 2004; Constant, et al., 2006; 
Hoffert-Goeres, et al., 2007; Palmieri, et al., 2008; Ledgard, et al., 2009; Guillomot, et 
al., 2010). 
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To our knowledge, this is the first study to document clearly the atypical 
expression of some of principal steroidogenic genes in bovine placenta from early 
SCNT pregnancies. The aberrant expression of the above mentioned genes would 
cause insufficiency in some proteins and enzymes, which participate in the 
synthesis of diverse steroids as: pregnenolone, progesterone, estrogen precursors 
and estrone sulfate. Thereby, steroidogenic dysfunctional genes might lead to a 
wide range of effects on placental and fetal growth that could compromise the 
proper progression of pregnancy at short or long term. However, the western blot 
results did not show significant differences in STAR, CYP11A1 and HSD3B1 
abundance in SCNT gestations versus non-clone pregnancies. Although no 
significant difference in expression of HSD3B1 protein was found, one sample from 
SCNT group expressed this enzyme strongly. This fact suggests the possibility that 
not all cloned embryos have the same disturbances, since the variation in mean 
expression levels could mask gene expression abnormalities present in individual 
clones. Some authors (Campos, et al., 2010), have noted the importance of 
individual analyses of cloned animals.  Moreover, differences found between early 
and late gestations, may be associated with individual compensatory mechanisms 
that could be triggered during gestation in order to overcome disrupted expression 
of important genes in the placenta, as previously  reported (Constant, et al., 2006). 
 Interestingly, and in disparity with our results, some authors reported 
upregulation of SULT1E1 and CYP11A1 mRNA expression in SCNT preterm and 
term placentas (Everts, et al., 2008; Hirayama, et al., 2008). The differences found 
between SCNT early and late gestation might be associated with individual 
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compensatory mechanisms that could be triggered during gestation in order to 
overcome disrupted expression of important genes in the placenta, as previously 
reported (Constant, et al., 2006).  
In summary, disruption in the expression of important steroidogenic 
markers in SCNT placenta could be translated into insufficient biosynthesis of 
steroid hormones, and also in inadequate placental and fetal growth. However, 
whether trigger of the aberrant gene expression is part of combination of 
insufficient reprogramming that could be key origin of placental dysfunction, or 
just a consequence of abnormal placental development is yet to be established.  
In chapter V, we elucidated of the factors, which control the synthesis of 
progesterone in bovine placentome explants at 140 +10 days of gestation.  
Although previous studies have identified the principal factors and 
intracellular pathways involved in regulation of steroidogenesis in the gonads and 
adrenal glands, very little is known about the regulation of such steroidogenic 
factors in bovine placenta.  Owing to the results obtained in chapter III, regarding 
the bovine feto-maternal unit as a complex system controlling the steroidogenesis 
process, we sought an in vitro culture system that would allow us to maintain 
together the fetal and maternal compartments to study more precisely the 
mechanisms for the control of placental steroidogenesis.  We tried several 
approaches in vitro for the isolation and culture of different placental cell 
populations (density separation by Percoll and flow cytometry). However these 
approaches did not allow us to study the bovine placenta as a feto-maternal unit, as 
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happens in vivo conditions.  We therefore developed a placentome explant model 
of bovine gestation around days 140 +10, based on previous studies with human 
and equine placental explants (Fuglsang, et al., 2008; Nash, et al., 2008). Our 
objective in the chapter V was to examine the principal intracellular pathways and 
factors implicated in the regulation of the steroidogenic process in bovine placenta 
at 140 +10 days of gestation. The effect of chorionic gonadotrophin and second 
messengers on progesterone synthesis and steroidogenic proteins from cultured 
placental explants was studied. We measured progesterone levels in culture media 
by RIA, and steroidogenic transcripts and protein by qPCR and western blot. 
However in the present chapter only transcript results are shown, protein analyses 
are still ongoing; and once these analyses have been finished, the final manuscript 
will be submitted to a scientific journal.  
 Before investigating the effect of the hCG on cultured placental explants, we 
determined the presence of luteinizing hormone receptor transcript in caruncular 
and cotyledonary tissues. In our understanding the present work demonstrated for 
the first time the presence of mRNA for LH receptor in bovine placenta. 
In the present study, progesterone production by placentome explants was 
only significantly stimulated by calcium ionophore at all periods investigated. 
Moreover steroidogenic transcripts of the principal protein (STAR) and enzymes 
(STAR, CYP11A1, HSD3B1 and SULT1E1) involved in the synthesis of steroids and 
steroids sulfates were also stimulated by this calcium analogue at different periods.  
This indicates that in bovine placenta, apparently the calcium influx stimulates the 
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progesterone production by increasing the cholesterol transport into the 
mitochondria and the rate of conversion cholesterol-pregnenolone, pregnenolone- 
progesterone, and estrogen-estrone sulfates by the activation of the 
aforementioned enzymes. Previous investigation in bovine placenta found the same 
stimulatory effect of the calcium analogue on progesterone formation; however 
these authors did not evaluate the effect of calcium on the principal steroidogenic 
enzymes (Shemesh, et al., 1984; Shemesh, et al., 1988). The factors that could 
regulate calcium metabolism cells are not known, but studies on adrenal cells 
demonstrated that adrenal glucocorticoid synthesis is stimulated by the trophic 
hormone ACTH; and that its dominant second messenger for the stimulation of 
STAR protein expression is calcium (Yamazaki, et al., 2006). 
In gonads and adrenal gland, the trophic hormones were identified as the 
principal factors responsible for acute steroid stimulation (Steele & Leung, 1992; 
Saez, 1994; Ghayee & Auchus, 2007). Therefore, in this study we decided to explore 
the potential stimulatory effect of LH on progesterone synthesis in bovine placenta 
using the human placental LH analog, hCG. 
Contrary to what we expected, in our study, the progesterone levels were 
not affected by hCG or hCG +A23187 treatment, however the mRNA expression of 
STAR, CYP11A1, HSD3B1 and SULT1E1 was increased at different sampling times.  
In this experiment hCG, calcium ionophore and a combination of both 
increased mRNA abundance for SULT1E1 enzyme for almost all studied periods. 
186 
 
SULT1E1 is a metabolic enzyme that acts as estrogen regulator, transforming the 
active estrogens into sulfoconjugated estrogens which then lose their ability to 
interact with the estrogen receptor and are hormonally inactive (Rossier & 
Pierrepoint, 1974). Importantly, in bovine gestation an increase in estrogens is 
necessary for the labor and delivery process, and this augment is accompanied by a 
decrease in the sulfoconjugation activity (Hoffmann, et al., 2001; Senger, 2005). 
Nevertheless, there is a lack of information about the mechanisms that control the 
sulfoconjugation in bovine placenta. In mouse Leydig cells, estrogen 
sulfotransferase expression is under control of LH (Song, et al., 1997; Qian & Song, 
1999). Our findings may have significant implications for understanding the role of 
trophic hormones and calcium in the regulation of estrogen sulfoconjugation in 
bovine placenta. However, additional studies will be required to more precisely 
describe this regulation.  
On another front, even if hCG had an impact in the steroidogenic transcripts 
in placentome cultures, this stimulus was not of sufficient magnitude to increase 
considerably the synthesis of progesterone. This led us to speculate that this 
trophic hormone might not be considered the principal factor of regulation of 
steroidogenesis in bovine placenta. Even though the principal signaling pathways 
regulating steroidogenesis in adrenals and ovary are the activation of cAMP-
dependent protein kinase A (PKA) and protein kinase C (PKC) pathways 
(Nishikawa, et al., 1996; Luo, et al., 1998; Rekawiecki, et al., 2005; Miller, 2007), our 
findings suggest that in bovine placenta the synthesis of progesterone is modulated 
principally by intracellular calcium influx, and apparently cyclic nucleotides do not 
187 
 
seem to be controlling this process. It would be conceivable that calcium influx 
either directly or indirectly is regulated by other factors and mechanisms. Previous 
studies have demonstrated that PGE (1) Prostaglandin E(1) (PGE(1)), PGE (2), EGF, 
insulin-like growth factor (IGF), PRL, gonadotrophin-releasing hormone (GnRH) 
and MDFs participate in the regulation of steroid biosynthesis in gonads and 
adrenal glands (Weiss-Messer, et al., 1996; Sekar, et al., 2000; Hales, 2002; Manna, 
et al., 2009). Further research is necessary to understand the mechanisms and the 
molecular actions and the possible intracellular pathways in regulating calcium 
signaling and steroidogenesis in bovine placenta.  Moreover we do not exclude the 
possibility that multiple factors and second messenger systems may cross-talk with 
one another in placental steroidogenesis.  Finally, the placentome explants used 
here, provided a good model to mimic in vivo conditions to explore specific 
mechanisms underlying placental steroidogenesis, and possibly other process or 
pathologies in bovine placenta. 
 
  
  
 
 
 
CHAPTER 7. GENERAL CONCLUSIONS AND PERSPECTIVES 
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General Conclusions  
1. In this thesis, we demonstrated the capability of the early bovine placenta to 
initiate steroidogenesis, and also we determined the principal cells implicated 
in this process. Moreover, in contrast to the notion that in bovine placenta the 
steroids are produced by the trophoblast giant cells, our studies propose that 
during early pregnancy these cells are not a source of placental steroids, 
because they did not express the indispensable proteins for the steroidogenic 
process.  In more detail, we demonstrated that the caruncles expressed the full 
steroidogenic proteins needed for pregnenolone and progesterone synthesis. In 
contrast, the cotyledons only expressed the steroidogenic proteins required for 
pregnenolone production.  The aforementioned observations suggest that in 
early pregnancies, the maternal compartment exhibits greater steroidogenic 
capacity than fetal component, particularly for the synthesis of progesterone. 
However, we also observed than in early gestations the cotyledonary cells 
expressed a receptor and steroidogenic enzymes, which are responsible for the 
selective absorption of cholesterol into the cell, and also for pregnenolone and 
estrogen precursors’ synthesis in early gestations. In addition we found a 
complementary pattern of steroidogenic protein expression found between 
fetal and maternal compartments. 
Taking together our data suggest that synthesis of steroids is very distinctly 
partitioned at the cellular level within the placenta, but apparently cell to cell 
communication between the maternal and fetal cells is required for placental 
steroidogenesis.  
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2. In this study, we indentified, for the first time, significant alterations in the 
expression of a wide range of steroidogenic genes in bovine placenta from SCNT 
gestations.  Thus, we postulate that reduced expression of steroidogenic genes 
may cause an insufficient biosynthesis of steroid hormones, which potentially 
might lead to placental and fetal anomalies in SCNT gestations at short or long 
term. A better understanding of failures in physiological and/or genetic 
mechanisms essential for the placental and fetal development will be vital for 
developing new strategies to improve assisted reproductive techniques. 
 
3. To our knowledge, this thesis had demonstrated for the first time the presence 
of luteinizing hormone receptor transcript in bovine placenta; and also the 
stimulatory effect of hCG on steroidogenic genes in bovine placentomes.  
Moreover, calcium ionophore had a stimulatory effect on the progesterone 
levels and on the steroidogenic transcripts of the principal proteins involved in 
the synthesis of steroids and steroids sulfates. Based on these findings, we 
conclude that in bovine placenta the synthesis of progesterone is modulated 
principally by intracellular calcium influx, and apparently cyclic nucleotides do 
not seem to be controlling this process. In the present study, we developed an 
efficient placentome explants culture model that allow to mimic in vivo 
conditions to explore specific mechanisms underlying placental 
steroidogenesis, and possibly other process or pathology in bovine placenta.   
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4. Finally, understanding of the regulatory mechanisms of steroid synthesis and 
the role of placental steroids in the regulation of placental and fetal 
development could be a powerful tool in the development of potential 
preventive treatments to improve pregnancy outcomes after assisted 
reproductive techniques. 
Future perspectives 
The results shown in this thesis contribute to the elucidation of the principal 
hormonal, cellular and molecular mechanism in placenta controlling establishment 
and maintenance of bovine clone and non-clone pregnancies. Strategic 
manipulation of those physiological mechanisms may help to develop better 
therapeutic strategies to improve uterine capacity, conceptus survival, and 
reproductive health in domestic animals as well as humans.  Moreover, these new 
findings open up great opportunities to identify the origin and consequences of 
SCNT placental and fetal anomalies. Understanding the origin and consequences of 
SCNT placental and fetal anomalies, open up a great opportunity to develop 
potential preventive treatments to enable a better gestational outcome for cloned 
animals. 
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CHAPTER 9. ANNEXES 
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ANNEX 1.  Separation of subpopulation of  bovine placental cells by size, using 
fluorescence activated cell sorting method (FACS) 
Methodology  
Bovine gestations ranged 140 +10 days of gestation based on crown-rump lengths 
were collected from a local slaughterhouse. Caruncles and cotyledons were 
separated manually and cut into small sections (5 mm). Tissue pieces from 
caruncles and cotyledons,  were incubated and digested separately in a shaker for 
30 min at 37°C in a solution of collagenase (0.5%) diluted in Dulbecco's Modified 
Eagle Medium (DMEM) (1X), high glucose (Invitrogen Life Technologies 
Corporation, Burlington, ON, Canada) supplemented with antibiotics (100 U/ml 
penicillin and 100 µg/ml streptomycin). Enzymatic dispersion and trophoblast cells 
isolation was performed as described by (Nakano, Takahashi et al. 2001). The cell 
suspension for each tissue was sedimented by centrifugation at 800 x g for 20 min. 
The cells were washed and resuspended in DMEM and transported to the Flow 
Cytometry laboratory at the CRRA; to be separated by size, using the FACS method.  
 
 
Caruncle CotyledonA B
CEC
TGC UTC TGC
 
Figure 1. Isolation of different bovine placental cells by FACS in caruncular and 
cotyledonary tissues. Abbreviations: CEC caruncular ephithelial cells, TGC 
trophoblast giant cells and UTC uninucleate trophoblast cells.  
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ANNEX 2.  Preliminary studies to determine the viability and sampling time of 
bovine placentome explants 
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Figure 1. Progesterone (P4) concentrations after 1, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 
22 and 24 h of incubation to determine the viability and sampling time of placenta 
explants. Placentome explants from five bovine gestations around day 140 + 10 
were treated with high (15 µg/ml), medium (5 µg/ml) and low (1 µg/ml) doses of 
25-hydroxycholesterol (25OHC) as external source of cholesterol. The data are 
expressed as the mean + S.M.E.  
 
Nakano, H., T. Takahashi, et al. (2001). "Expression of placental lactogen and cytokeratin in 
bovine placental binucleate cells in culture." Cell Tissue Res 303(2): 263-270. 
 
 
 
